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ABBREVIATIONS  
 
Ca
2+
   Calcium 
 
[Ca
2+
]c   Cytoplasmic calcium concentration 
 
[Ca
2+
]m  Mitochondrial calcium concentration 
 
acetyl-CoA  acetyl coenzyme A 
  
ADP   Adenosine 5’ diphosphate 
 
ANT   Adenine Nucleotide Translocase 
 
ATP   Adenosine 5’ triphosphate 
 
[ATP]m  mitochondrial ATP 
 
ATP5A ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 
subunit 
 
Bcl-2   B cell leukemia/lymphoma 2 
 
CaM   Ca
2+
-calmodulin 
 
CaMK   Ca
2+
-calmodulin kinase 
 
Cdk   Cyclin-dependent kinase 
 
CsA   Cyclosporine A 
 
DAG   Diacylglycerol 
 
DOA   Dominant Optic Atrophy 
 
DRP1   Dynamin Related Protein 1 
 
EMRE   Essential MCU Regulator 
 
ER   Endoplasmic Reticulum 
 
ETC   Electron Transport Chain 
 
FACS   Fluorescence-Activated Cell Sorting 
 
FAD   Flavin Adenine Nucleotide 
 
FCCP   Carbonyl Cyanide –p- trifluoromethoxyphenylhydrazone 
 
GFP   Green Fluorescent Protein 
 
HIF1α   Hypoxiainducible Factor 1α 
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HA   Hemagglutinin 
 
HK   Hexokinase II 
 
HtrA2   High temperature requirement protein A2 
 
IAP   Inhibitor of Apoptosis Protein 
 
IB   Intracellular Buffer 
 
IMM   Inner Mitochondrial Membrane 
 
IMS   Intermembrane Space 
 
IP3   Inositol 1,4,5-trisphosphate 
 
MAM   Mitochondria Associated Membrane 
 
MCU   Mitochondrial Calcium Uniporter 
 
MCUR1  Mitochondrial Calcium Uniporter Regulator 1 
 
MEFs   Mouse Embryonic Fibroblasts 
 
mgluR1  matabotropic glutamate Receptor 
 
MICU1  Mitochondrial Calcium Uptake 1 
 
m   Mitochondrial membrane potential  
 
MPT   Mitochondrial Permeability Transition 
 
mPTP   mitochondrial Permeability Transition Pore  
 
mtGFP  mitochondrial Green Fluorescent Protein 
 
NCLX   mitochondrial Na
+
/Ca
2+
 antiporter 
 
OMM   Outer Mitochondrial Membrane 
 
pHH3   phosphohistone H3 
 
PI   Propidium Iodide 
 
PiC   inorganic Phosphate Carrier 
 
Pin1   Peptidyl-prolyl cis/trans isomerase 
 
PIP2   Phosphatidylinositol-4,5-biphosphate 
 
PPIF   Peptidyl Prolyl Isomerase F 
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RNA pol II  RNA polymerase II 
 
RNS   Reactive Nitrogen Species 
 
ROS   Reactive Oxygen Species 
 
siRNA   short interfering RNA 
 
TCA   Citric Acid Cycle 
 
TSPO   Peripheral Benzodiazepine Receptor 
 
VDAC   Voltage-Dependent Anion Channels 
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INTRODUCTION 
 
Mitochondrial structure and functions 
 
Mitochondria 
 
Mitochondria are organelles with complex structures and functions. They are derived from 
an α-proteobacterium-like ancestor, due to an ancient “invasion” that occurred more than a 
billion years ago [1] The acquisition of mitochondria (and plastids) was a key event in the 
evolution of the eukaryotic cell, supplying it with bioenergetic and biosynthetic factors. 
At subcellular resolution mitochondria are composed of an outer membrane (OMM), 
mostly permeable to ions and metabolites up to 10 kDa, and a highly selective inner 
mitochondrial membrane (IMM), characterized by invaginations called cristae. The space 
between these two structures is called the intermembrane space (IMS). Together, the OMM 
and IMM enclose the mitochondrial matrix. The IMM is further subdivided into two 
compartments: the peripheral inner boundary membrane and the cristae [2]. Cristae are not 
simply random folds, but rather internal compartments formed by profound invaginations 
originating from very tiny “point-like structures” in the inner membrane. These narrow 
tubular structures, called cristae junctions, can limit the diffusion of molecules from the 
intra-cristae space towards the IMS, thus creating a microenvironment where 
mitochondrial electron transport chain (ETC) complexes (as well as other proteins) are 
hosted and protected from random diffusion. The inner boundary membrane is enriched 
with structural proteins and components of the import machinery of mitochondria [3]. 
Mitochondrial morphology in living cells is heterogeneous and can range from small 
spheres to interconnected tubules. This heterogeneity results from the balance between 
fusion and fission processes, and represents a phenomenon termed mitochondrial dynamics 
[4]. A growing body of evidence indicates that mitochondrial morphology is critical for the 
physiology of the cell and changes in mitochondrial shape have been related to many 
different processes such as development, neurodegeneration, calcium (Ca
2+
) signalling, 
reactive oxygen species (ROS) production, cell division, and apoptotic cell death [5]. 
Mitochondrial shape is controlled by the recently identified “mitochondria-shaping 
proteins”, which regulate the fusion-fission equilibrium of the organelle. In mammals, key 
components of the fusion machinery include the homologues MFN1 and MFN2 [6]. The 
only dynamin-like GTPase currently identified in the IMM is OPA1, a fusion protein that 
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is mutated in dominant optic atrophy (DOA), the most common cause of inherited optic 
neuropathy. Post-transcriptional mechanisms, including proteolytic processing, tightly 
regulate OPA1 activity. In mammalian cells, mitochondrial division is regulated by DRP1 
and FIS1 [7, 8]. The large GTPase DRP1 is a cytosolic dynamin-related protein, whose 
inhibition or downregulation results in a highly interconnected mitochondrial network. The 
same phenotype is caused by the downregulation of FIS1, a protein of the OMM, proposed 
to act as a mitochondrial receptor for DRP1 [9]. For example, mitochondrial dynamics 
seem to influence production of ROS and cellular longevity. DRP1-dependent 
fragmentation of the mitochondrial reticulum is a crucial component for accumulation of 
ROS in pathological conditions [10]. How mitochondrial fission is required for ROS 
production and lifespan remains unclear, although a link between the two processes seems 
plausible. Hence, factors other than mitochondrial metabolism per se could have a role in 
the pathogenesis of ROS-related diseases. Interestingly, many ROS (as well as Reactive 
Nitrogen Species, RNS) sources and targets are localized in the mitochondria and ER with 
are relevant consequences for different pathways [11]. 
Within cells, energy is provided by oxidation of “metabolic fuels” such as carbohydrates, 
lipids and proteins. It is then used to sustain energy-dependent processes, such as the 
synthesis of macromolecules, muscle contraction, active ion transport or thermogenesis. 
The oxidation process results in free energy production that can be stored in 
phosphoanhydrine “high-energy bonds” within molecules such as nucleoside diphosphate 
and nucleoside triphosphate (i.e., adenosine 5' diphosphate and adenosine 5’ trisphosphate, 
ADP and ATP, respectively), phosphoenolpyruvate, carbamoyl phosphate, 2,3-
bisphosphoglycerate, and other phosphates like phosphoarginine or phosphocreatine. 
Among them, ATP is the effective central link-the exchange coin-between energy 
producing and the energy demanding processes that effectively involve formation, 
hydrolysis or transfer of the terminal phosphate group. 
In general, the main energy source for cellular metabolism is glucose, which is catabolized 
in the three subsequent processes: glycolysis, tricarboxylic acid cycle (TCA or Krebs 
cycle), and finally oxidative phosphorylation to produce ATP. In the first process, when 
glucose is converted into pyruvate the amount of ATP produced is low. Subsequently, 
pyruvate is converted to acetyl coenzyme A (acetyl-CoA) which enters the TCA cycle, 
enabling the production of NADH. Finally, NADH is used by the respiratory chain 
complexes to generate a proton gradient across the inner mitochondrial membrane, 
necessary for the production of large amounts of ATP by mitochondrial ATP synthase. In 
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addition, it should be mentioned that acetyl-CoA could be generated also by lipid and 
protein catabolism. 
 
 
Citric Acid Cycle, Respiratory Chain and Oxidative Phosphorylation 
 
The citric acid cycle (TCA) was elucidated by Sir Hans Krebs in 1940 [12]. The triose 
deriving from glycolysis is completely oxidized into three molecules of CO2 during a 
sequence of reactions that allow the reduction of cofactors NAD and flavin adenine 
nucleotide (FAD), providing energy for the respiratory chain in the form of electrons. In 
1949 Kennedy and Lehningher demonstrated that the entire cycle occurs inside 
mitochondria [12]. The first reaction of the citric acid cycle is the condensation of one 
Acetyl-CoA and a molecule of citrate to generate oxaloacetate and is catalysed by citrate 
synthase. Citrate is then transformed into isocitrate by aconitase through the formation of 
cis-aconitate. This step is reversible and could lead to the formation of both citrate and 
isocitrate. Only the fast consumption of isocitrate by its dehydrogenase can force the 
reaction to the proper direction. Isocitrate dehydrogenase catalyses the first irreversible 
oxidation leading to the decarboxylation of isocitrate, generating CO2 and α-ketoglutarate. 
The second carbon leaves the cycle in the following step, when the newly generated α-
ketoglutarate is immediately decarboxylated by the α-ketoglutarate dehydrogenase 
complex in a reaction similar to the pyruvate decarboxylation. In fact, both these 
complexes share high similarities in enzyme amino acid composition and in the 
organization of the different subunits. Energy released from both oxidations is used to 
generate NADH from NAD that directly feeds into the respiratory chain. 
The following step is catalysed by succinyl-Coa synthetase and utilizes the energy derived 
from the CoA removal to phosphorylate GDP (or ADP) to GTP (or ATP). Selectivity for 
the nucleotide is determined by the isozyme involved. It has been well established that at 
least two isozymes of succinyl-CoA synthetase are expressed in animal tissues [13] and the 
proportion between them seems to be tissue specific. 
The succinate generated in the previous step is the 4 carbon compound that is then 
converted, by three sequential reactions, to oxaloacetate to conclude the cycle. The first of 
these steps is the oxidation of succinate to fumarate by succinate dehydrogenase. This 
enzyme, tightly bound to the inner mitochondrial membrane (IMM), catalyses FAD 
reduction to FADH2 that provides electrons for the respiratory chain. Fumarate is then 
hydrated by fumarate hydratase to L-malate. Both succinate dehydrogenase and fumarate 
 9 
hydratase are oncosuppressor genes and their inactivation leads to the accumulation of 
succinate and fumarate that spread in the cytosol and promote hypoxiainducible factor 1α 
(HIF1α) accumulation by inactivating prolyl hydroxilase enzymes (promoter of HIF1α 
degradation); HIF1α, promotes a pseudo-hypoxic condition that favours tumour 
development [14]. The last event that completes the citric acid cycle is the oxidation of L-
malate to oxaloacetate. This reaction is performed by L-malate dehydrogenase, which 
induces the reduction of another molecule of NAD to NADH. The resulting molecule of 
oxaloacetate is suitable for starting another cycle through condensation with an acetyl 
group. 
During all these processes, only one molecule of ATP (or GTP) is produced, but three 
molecules of NADH and one of FADH2 (plus one molecule of NADH from pyruvate 
dehydrogenase), which provide electrons for respiratory chain, are also generated and 
subsequently result in the production of large amounts of ATP [15]. 
The mitochondrial respiratory chain comprises a series of protein complexes and fat-
soluble compounds which act as electron carriers and the majority of which are integral 
membrane proteins containing prosthetic groups capable of accepting or donating one or 
two electrons. It is located in the IMM and is able to produce an electrochemical potential 
across the mitochondrial membrane by creating a concentration gradient of H
+
 ions 
between the two sides of the membrane. This potential is exploited to activate the transport 
channels present on the membrane and to promote the synthesis of ATP by ATP synthase. 
The electron carriers of the respiratory chain are organized in separated supramolecular 
intramembrane complexes, and each of them represents a fraction of the respiratory chain 
(Fig. 1). 
The complexes of the respiratory chain are:  
 Complex I: NADH dehydrogenase  
 Complex II: Succinate dehydrogenase  
 Complex III: cytochrome c reductase  
 Complex IV: Cytochrome c oxidase 
All complexes are formed by multiple subunits and contain all the proteins encoded by 
nuclear DNA that is mitochondrial, except the Complex II which is entirely encoded by 
nuclear DNA. Coenzyme Q (ubiquinone) transfers the electrons previously transported in 
complex I and complex II from NADH and FADH2 to complex III, and hence they will be 
conducted to complex IV by cytochrome c. It eventually transfers electrons directly to 
oxygen, leading to H2O production. 
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Coenzyme Q (also called ubiquinone) is located between Complex I and Complex III and 
can accept only one electron, becoming a semiquinone radical, or two electrons acquiring 
the fully reduced ubiquinol form. Since ubiquinone is small in size and hydrophobic, it is 
freely diffusible in the lipid bilayer of the IMM and can act as a bridge between less 
mobile electron carriers in the same membrane. 
The cytochrome c is also an essential part of the ETC. It is a peripheral membrane protein 
of 12.5 KDa soluble in water and weakly associated with the external surface of IMM due 
to interaction with cardiolipin [16]. This protein transfers electrons between complexes III 
and IV. Like all cytochromes it has a prosthetic group (heme group) and it is constituted by 
a tetrapyrrolic ring with an iron atom covalently bonded to the center. Cytochrome c 
allows the passage of electrons through the oscillation of the iron from the ferric form Fe
3+
 
to the ferrous form Fe
2+
. 
The chemical mechanism which couples the proton flow with the phosphorylation is called 
Chemiosmotic Model and it was proposed by Peter Mitchell [17]. In agreement with this 
model the electrochemical energy contained in the difference of proton concentration and 
in the charge separation across the IMM leads to the synthesis of ATP when the proton 
flow reverses its direction and protons back into the matrix through a proton channel 
associated to the ATP synthase. The mechanism of action of ATP synthase was elucidated 
by the Nobel Prizes Paul Boyer and John Walker. ATP synthase could be divided in two 
main components: Fo that allows the channelling of protons, and F1 that catalyses ATP 
phosphorylation. The Fo is embedded in the IMM, while the F1 resides in the mitochondrial 
matrix and is bound to the Fo through a γ subunit (which drives conformational changes) 
and a b2δ dimer (that holds Fo and F1 together). The protons flow from the intermembrane 
space to the matrix through the Fo inducing its rotation; the movement is transmitted from 
the γ subunit to the F1 causing conformational rearrangements. The Fo region consists of 
three main subunits a (ATP6 gene), b (ATP5F1 gene) and c (ATP5G1, ATP5G2 and 
ATP5G3 genes), and in humans six additional subunits d, e, f, g, F6 and 8. The F1 has a 
trimeric structure consisting of αβ dimers. The sequential changes are linked to the binding 
of substrates, phosphorylation and release of ATP. The three available dimers are never in 
the same conformational state and the conformational changes in one dimer drive 
rearrangements in the other [18]. This region consists of different protein subunits, α 
(ATP5A1 and ATPAF2 genes), β (ATP5B, ATPAF1 and C16orf7 genes), γ (ATP5C1 
gene), δ (ATP5D gene) and ε (ATP5E gene). It has been calculated that for the synthesis of 
one ATP molecule, 4 protons are required [19]. Once synthetized, ATP can locate inside 
mitochondrial matrix or be transported into the IMS by the nucleotide exchanger adenine 
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nucleotide translocase (ANT) that passively exchanges ATP with ADP. Once in the IMS, 
ATP can freely pass the OMM through the voltage dependent anion channel (VDAC).  
 
 
 
Figure 1: Schematic representation of mitochondrial electron transport chain [20]. 
 
A recent our work by Bonora et al. suggested moreover that the c subunit of the Fo ATP 
synthase constitutes a critical component of the mitochondrial Permeability Transition Pore 
(mPTP) and that it is required for the MPT, mitochondrial fragmentation and cell death 
induced by oxidative stress or mitochondrial Ca
2+
 overload [21]. However this part will be 
discussed more extensively in the thesis. 
The concentration gradient of H
+
 ions that is created between the two sides of the 
membrane is equivalent to a proton motive force and this is defined mitochondrial 
transmembrane potential which corresponds to -150/-180 mV in the cytosol [22]. This is 
essential for many processes, including the production of ATP by ATP synthase and the 
accumulation of Ca
2+
. Dysfunction of the respiratory chain are associated with 
mitochondrial disorders and affect tissues that require a large amount of energy as the 
brain, heart and skeletal muscle [23].  
Mitochondrial DNA encodes thirteen polypeptides, each of which is an integral subunit of 
respiratory chain complexes [24]. 
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Mitochondria and cell fate 
 
Mitochondria are also important checkpoints of the apoptotic process, as they may release 
caspase cofactors [25].  
Apoptosis, or programmed cell death, is a highly regulated cellular event that plays an 
extremely important role in the tissue homeostasis and in the development of multicellular 
organisms. Defects in regulation of apoptosis are often associated with pathological 
conditions such as neurodegenerative diseases, tumorigenesis, autoimmune syndromes and 
viral infections. Apoptosis occurs through two pathways: the extrinsic pathway and the 
intrinsic or mitochondrial mitochondrial pathway, and it requires the action of specific 
enzymes (caspases) and regulatory proteins (such as those of the family Bcl-2). From the 
biochemical point of view, apoptosis is a proteolytic event generated by the activation of a 
large family of proteases called caspases (cysteine aspartate-specific proteases), generally 
present in the cytoplasm in the form of inactive enzymes. 
The main player in the apoptotic activation process is cytochrome c. The majority of 
cytochrome c is tightly bound to mitochondrial inner membrane, thanks to its electrostatic 
interactions with acidic phospholipids, but a small fraction probably exists loosely attached 
to inner mitochondrial membrane and available for mobilization. 
This protein is an irreplaceable component of the mitochondrial electron transport chain, 
shuttling electrons from complexes III to IV, and is thus essential to life: the disruption of 
its only gene is embryonic lethal [26]. Once released in the cytoplasm, this protein drives 
the assembly of a caspases activating complex together with Apaf-1 (apoptosis–protease 
activating factor 1) and caspase 9, the so-called ‘apoptosome’. Cytochrome c, once in the 
cytosol, induces the rearrangement and heptaoligomerization of Apaf-1: each of these 
complexes can recruit up to seven caspase molecules, leading to their proteolytic self-
processing and consequent activation [27]. Mitochondria contain several other 
proapoptotic, intermembrane space-resident proteins, such as Smac/ DIABLO, HtrA2/Omi, 
AIF and EndoG. DIABLO (direct inhibitor of apoptosis-binding protein with a low 
isoelectric point) and HtrA2 (high temperature requirement protein A2) both have an N-
terminal domain that can interact and inhibit IAPs (inhibitor of apoptosis proteins).  
Another event that accompanies apoptosis is the loss of mitochondrial membrane potential 
caused by the opening of the PTP. The opening may be triggered by several factors, such 
as an excessive accumulation of Ca
2+
, ATP depletion, oxidative stress, increased fatty 
acids or inorganic phosphate. PTP opening causes mitochondrial depolarization, followed 
immediately by mitochondria swelling, rupture of the OMM, release of cytochrome c and 
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other apoptotic factors, caspases activation and cell death by apoptosis. It is interesting to 
underline the important role of Ca
2+
 in this event, demonstrating how the mitochondrial 
Ca
2+
 signal represents a complex signaling pathway that mitochondria can translate in 
different biological consequences. 
Moreover, mitochondria are the most important source of intracellular reactive oxygen 
species and leak from the electron transfer chain is supposed to be the main route [28]. An 
unexpected pathway has emerged that involves p66Shc in mitochondrial reactive oxygen 
species production. Intriguingly, upon phosphorylation by PKCβ and peptidyl–prolyl 
cis/trans isomerase (Pin1) recognition, p66Shc translocates to mitochondria [29] where it 
exerts its own oxidoreductase activity [30]. As a consequence, p66shc directly oxidizes 
cytochrome c (thus allowing electron to escape mitochondrial electron transport chain) and 
generates H2O2, leading to mPTP opening and in turn cell death [31] (Fig. 2). 
 
 
 
Figure 2: Signal transduction pathway of p66Shc in oxidative condition [31]. 
 
The study of Ca
2+
 homeostasis in apoptotic process has highlighted some important 
regulators of apoptosis, such as proteins of Bcl-2 family, which are located in 
compartments deeply involved in the intracellular Ca
2+
 levels regulation (mitochondria and 
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endoplasmic reticulum (ER)). Indeed, Bcl-2 was found to be associated to OMM, ER and 
nucleus; there is also a cytoplasmic form of Bcl-2 [32]. The Bcl-2 protein family controls 
the intrinsic pathway of apoptosis.  
Proapoptotic Bax and Bak proteins exist as inactive monomers in viable cells with Bax 
localizing in the cytosol, loosely attached to membranes, and Bak residing in mitochondrial 
fraction. Upon apoptosis induction, Bax translocate to mitochondria where it homo-
oligomerizes and inserts in the outer membrane; similarly, also Bak undergoes a 
conformational change, which induces its oligomerization at the outer mitochondrial 
membrane. Together, these events trigger OMM permeabilization, the crucial process 
mediating the release of intermembrane space-resident caspase cofactors into the 
cytoplasm [33]. 
Mitochondria also undergo a more ‘macroscopic’ remodelling of their shape during the 
programed cell death. Indeed, after apoptosis induction, mitochondria become largely 
fragmented, resulting in small, rounded and numerous organelles. This process occurs 
quite early in apoptotic cell death, soon after Bax/Bak oligomerization, but before caspase 
activation.  
Mitochondrial and ER networks are also fundamental for the maintenance of cellular 
homeostasis and for the determination of cell fate under stress conditions [34]. The 
communication between the two organelles takes place via a zone of close contact between 
ER and mitochondria, called MAM (mitochondria associated membrane) [35], involved in 
bioenergetics and cell survival. 
 
The intracellular Ca
2+
 signalling 
 
In resting cells the [Ca
2+
]c is carefully maintained at extremely low levels (100 nM), while 
the concentration of the ion in the extracellular space is about 1 mM. There are also 
intracellular organelles, such as the ER and secretory granules, which contain one to ten 
thousand fold greater concentrations of Ca
2+
 than the cytoplasm. There is an electric 
gradient between the two sides of the plasma membrane, which stands on values between -
10 and -70 mV. The cell then spends a significant proportion of this energy against 
electrochemical gradient to maintain the concentration of this ion on such low values. 
However, in response to different stimuli the amount of the cation may increase 
significantly, up to 1-3 μM. The rapid increase in [Ca2+] in the cytoplasm is therefore one 
of the main features of the complex Ca
2+
 signal at the cellular level. The effect of this 
increase was correlated with an increasing number of physiopathological events. Muscle 
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contraction, hormone secretion, synaptic transmission, as well as the proliferation and 
apoptosis are just a few examples of Ca
2+
-mediated processes. The fundamental question is 
how it is possible that different events may be regulated by a single messenger. The answer 
is found in the versatility of the Ca
2+
 signal. 
In recent decades the huge amount of research done in this field has in fact revealed that 
the differences in amplitude, speed, and spatio-temporal characteristics of the [Ca
2+
] 
increase play an essential role in different events mediation. 
This versatility is ensured by the great complexity of the systems to regulate the Ca
2+
 
homeostasis: a lot of proteins (channels, pumps, receptors, enzymes, etc.) in fact 
collaborate in calcium signal activation, shutdown, and translation, and by the interaction 
with each other create many different spatio-temporal profiles of the signal responsible for 
the versatility and flexibility of the tasks of this intracellular messenger.  
The processes that shape the Ca
2+
 signalling in all its complexity can be schematically 
divided into four functional units [36]: 
- stimuli that produce messengers able to mobilize Ca2+ ions; 
- the consequent Ca2+ signalling activation that feed Ca2+ into the cytoplasm;  
- the role of Ca2+ as a second messenger; 
- the OFF mechanisms of Ca2+ signalling, composed of pumps and exchangers that 
remove Ca
2+ 
from the cytoplasm to restore resting conditions. 
It is very important to discuss now the role of Ca
2+
 signalling in mitochondria. In the 
sixties in fact a lot of studies conducted in isolated organelles have demonstrated the ability 
of energized mitochondria to accumulate Ca
2+
 [37]. This has quickly found an explanation 
in the chemiosmotic theory that was becoming popular in those years. It became clear that 
the proton gradient generated by the activity of the respiratory chain may be used not only 
for the synthesis of ATP, but also to accumulate cations in the matrix. 
Precisely the proton gradient determines the mitochondrial potential of about -180 mV 
(negative inside the organelle), which provides the driving force necessary to support the 
Ca
2+ 
influx into the mitochondria. It has been calculated that the equilibrium would be 
reached only if the [Ca
2+
] in the matrix reached values 10
6
 times higher than those present 
in the cytosol. Furthermore, the inhibition of the respiratory chain or the collapse of the 
membrane potential blocks the ability of mitochondria to accumulate the cation. 
The development of new indicators such as aequorin allowed to demonstrate that the 
increase in [Ca
2+
]c in live and intact cells induced by physiological stimuli is always 
accompanied by a parallel increase in mitochondrial matrix [Ca
2+
], where it reaches levels 
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much higher than in the cytosolic compartment (up to 500 μM in chromaffin cells). We can 
say that mitochondria play an active role in the signaling pathway of Ca
2+
. 
Mitochondrial Ca
2+ 
uptake plays a key role in the regulation of many cellular functions, 
ranging from ATP production to cell death. Increases in mitochondrial calcium activate 
several dehydrogenases and carriers, inducing an increase in the respiratory rate, H
+
 
extrusion, and ATP production necessary for the correct energy state of the cell. However, 
prolonged increase in [Ca
2+
]m leads to the opening of the mitochondrial permeability 
transition pore (mPTP), a critical event driving to cell death by apoptosis [38]. 
Although it is generally accepted that cellular energy metabolism, survival and death are 
controlled by mitochondrial Ca
2+
 signals, the underlying molecular mechanisms have been 
completely elucidated yet.  
The mitochondrial Ca
2+
 uptake and release mechanisms are based on the utilization of 
gated channels for Ca
2+
 uptake and exchangers for release that are dependent upon the 
negative mitochondrial membrane potential, which represents the driving force for Ca
2+
 
accumulation in the mitochondrial matrix [39]. 
There are several proteins involved in mitochondrial Ca
2+
 influx and efflux, such us the 
mitochondrial calcium uniporter (MCU) [40, 41] and the mitochondrial Na
+
/ Ca
2+
 
antiporter (NCLX) [42]. It is mostly accepted that Na
+
/Ca
2+ 
exchange activity is relevant 
for excitable cells [43] and that NCLX inhibition or silencing does not completely arrest 
Ca
2+
 efflux [42], which indicates that other mechanisms are involved in this process. Two 
mechanisms have been proposed to supplement Ca
2+ 
efflux, one based on the H
+
/Ca
2+ 
antiporter [44] and another based on the mPTP [45], but evidence supporting the latter 
remains elusive (Fig. 3). 
In particular this thesis focuses the attention on MCU and mPTP complex that are involved 
in the maintenance of mitochondrial Ca
2+ 
homeostasis and more details are shown below. 
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Figure 3: Schematic representation of mitochondrial calcium signalling. 
 
Ca
2+
 signalling and cell cycle 
 
Ca
2+
 signalling plays a crucial role in every cellular process, such us the origin of life, the 
fertilization and cell death. Several lines of evidence suggest that the intracellular Ca
2+
 
concentration influences mitogenic signals that control the progression of the cell cycle. 
Despite these strong indications, little attention is paid to the role that Ca
2+
 has on this 
process [46]. 
In eukaryotes, Ca
2+
-calmodulin (CaM) is one of the proteins more sensitive to Ca
2+
, which 
constitutes a family of Ser/Thr kinases that are able to stimulate the Ca
2+
-calmodulin 
kinase (CaMK). These proteins are involved in cell cycle regulation, in particular the G1/S 
phase progression and the exit from mitosis are dependent on changes in the concentration 
of CaM. The Ca
2+
 binding induces a modification of CaM and this is able to activate 
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several targets, such as ion channels and protein kinases. The selective inhibition of 
CaMKI leads to a block in the G1 phase due to a decrease in the cyclin D levels, an 
increased phosphorylation of pRb and prevention of the activation of cyclin-dependent 
kinases (Cdk) 4. The other isoform CaMKII is implicated in the progression into S phase, 
but also in the G2 and M phases [47]. 
Another protein involved in Ca
2+
 signalling is calcineurin, a heterodimer composed by the 
catalytic subunit calcineurin A and the regulatory, Ca
2+
-binding subunit calcineurin B. This 
protein is activated as a result of changes in intracellular [Ca
2+
] and it controls the cell 
cycle progression with the proteins of the CaMK family. In particular, in the G1 phase 
inhibition of both proteins stops the cycle before the activation of the cyclin D1/Cdk4 
complex. During the G1/S transition, the inhibition of calcineurin and CaMK leads to the 
accumulation of p21 and p27 respectively, the increase of the levels of these proteins is 
sufficient to inactivate Cdk2 and to block the cell cycle. Finally, CaMKII is the target of 
CaM during the G2/M transition and also during the metaphase/anaphase transition [48]. 
Changes in the mRNA of CaM are associated with a transition of cells from G1 phase to 
the quiescent phase. CaMs are also capable of activating DNA polymerase α and δ, 
indicating a role in the PCNA transcription. Ca
2+
 and CaM are involved also in the 
breakdown of the nuclear envelope, cytokinesis and in the contraction of myosin’s ring 
[46]. 
 
MCU, the Mitochondrial Calcium Uniporter 
 
Ca
2+
 accumulation into mitochondria plays a fundamental role in many cellular processes 
and occurs through the uniporter, thanks to a mechanism driven by the membrane potential 
generated by the respiratory chain. The activity and biochemical properties of the MCU 
have been characterized for years, but the molecular identity of the channel has remained 
unknown for a long time [49]. 
The molecular characterization of MCU was a major challenge for several reasons, 
including the lack of a selective inhibitor (the uniporter was inhibited not specifically by 
ruthenium red) and a yeast homolog of the uniporter.  
MCU has a low affinity for Ca
2+
; in fact, MCU takes up Ca
2+
 in the micromolar range and 
experiments in permeabilized cells report a Kd of the uniporter of 10 M [50]. In addition, 
a biphasic effect of calcium on the MCU has been reported: beyond a certain level, 
cytosolic Ca
2+
 inactivates the uniporter, preventing further Ca
2+
 uptake and this process 
might avoid an excessive accumulation of the cation in mitochondria [51].  
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Initially the candidates proposed for the MCU were the uncoupling proteins UCP2/3 [52], 
but this suggestion was then retired [53]. Recently, Perocchi and colleagues [54] 
demonstrated that MICU1 (mitochondrial calcium uptake 1) has a key role in regulating 
the classically defined uniporter.  
Finally in 2011 it has been discovery the molecular identity of MCU, the coiled-coil 
domain-containing protein 109A (CCDC109A) [40, 41, 55].  
The nuclear MCU gene, located on chromosome 10, encodes for a protein of 40 kDa but it 
loses its target sequence when it is imported into the mitochondria. The result is a mature 
35-kDa protein expressed in all tissues, capable of oligomerization, giving rise to a 
complex of higher molecular weight [41]. 
From the topological point of view, the MCU is located in the IMM, with the N-terminal 
and the C-terminus facing the matrix; there is a linker of 9 aa (the DIME domain) facing in 
the IMS between the two transmembrane domains. The DIME domain is essential for the 
Ca
2+ 
transport because mutations inside it render the protein non-functional [41]. 
The overexpression of MCU increases mitochondrial Ca
2+
 uptake and sensitizes cells to 
apoptotic stimuli, and the employment of short interfering RNA (siRNA) silencing of 
MCU strongly reduced mitochondrial Ca
2+
 uptake. This reduction is specific for 
mitochondria, does not induce impairment of the electrochemical gradient or change in 
mitochondrial morphology and the induction of specific mutations at the level of the 
putative pore-forming region reduce the mitochondrial calcium uptake and blocks the 
channel activity of the protein [40]. Recently it was shown that miR-25, a small (22 
nucleotides) noncoding regulatory RNA overexpressed in several human cancers, 
decreases mitochondrial Ca
2+
 uptake through selective MCU downregulation, conferring 
resistance to apoptotic challenges. MCU appears to be downregulated in human colon 
cancer samples, and accordingly, miR-25 is aberrantly expressed, indicating the 
importance of mitochondrial Ca
2+
 regulation in cancer cell survival [56]. 
About MICU1, previously identified as regulator of MCU, recently it has been shown that 
it is a 54-kDa single-pass membrane protein containing two highly conserved EF-hand 
Ca
2+
-binding domains. Through [57] or independently [58] of these domains MICU1 
stabilizes the closed state of the MCU complex limiting mitochondrial Ca
2+
 entry.  
MICU1 has two paralogues (MICU2 and MICU3) possessing N-terminal mitochondrial 
targeting sequences. MICU2 localizes in mitochondria, it has a highly conserved EF-hand 
domain and interacts with MICU1 and MCU [59].  
It was also recently discovered another isoform of MCU, called MCUb. It is a protein of 33 
kDa that shares 50% of similarity with MCU. Its topology and structure is very similar to 
 20 
that of MCU. It has two transmembrane domains with the N-terminal and the C-terminus 
facing the IMS but it has a lower level of expression and a different expression profile 
compared to the MCU. MCUb might be a dominant-negative isoform and the insertion of 
one or more MCUb subunits in the multimer might alter the permeability to Ca
2+
 [60]. 
However the mRNA levels of MCUb are very low when compared to MCU levels; this 
mRNA is highly expressed in the heart and lungs and little expressed in skeletal muscle. 
Variations of tissue-dependent accumulation of mitochondrial Ca
2+
 have been reported, 
and the Ca
2+
 influx in skeletal muscle is 28-fold greater than in cardiac mitoplasts [61]. 
In 2012 it has been identified also a regulator of MCU, CCDC90A or MCUR1 
(mitochondrial calcium uniporter regulator 1), an integral membrane protein required for 
MCU-dependent mitochondrial Ca
2+
 uptake [62]. MICUR1 interacts with MCU but not 
with MICU1 and these three proteins do not exist in the same complex [62]. 
It has been identified also an essential MCU regulator (EMRE), it is a component of the 
uniporter complex and it interacts with MICU1 at IMS and with MCU oligomers in the 
inner membrane. [63]. 
Therefore the uniporter complex (uniplex) seems to be composed of MCU holomers, 
MCUb, MICU1, MICU2 and EMRE [63, 64]. 
The latest work by Patron et al. shows also that MICU1 and MICU2 finely tune the MCU 
by exerting opposite effects on MCU activity; at low [Ca
2+
] MICU2 largely shuts down 
MCU activity, at higher [Ca
2+
] MICU1 allows the response of mitochondria to Ca
2+
 signals 
generated in the cytoplasm [65]. 
Thus, MCU complex is important for mitochondrial Ca
2+
 uptake and the equilibrium of all 
the components manteins the normal cellular bioenergetics (Fig. 4). 
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Figure 4: Schematic representation of the different components of the uniporter complex [64]. 
 
mPTP, the mitochondrial Permeability Transition Pore 
 
The mPTP is a high-conductance channel located at the contact sites between the inner and 
outer mitochondrial membranes. This channel is responsible for the non-selective 
permeability state of the mitochondrial inner membrane. The transition to this state for 
small molecules is referred to as the MPT. Due to osmotic forces, MPT results in a massive 
influx of water into the mitochondrial matrix, eventually leading to the structural break- 
down of the organelle [25, 66]. 
The molecular composition of the mPTP is not yet clear, but several proteins have been 
shown to be components that participate in mPTP activity, including VDAC [67], ANT 
[68], the inorganic phosphate carrier (PiC) [69], peptidyl prolyl isomerase F (PPIF) [70, 
71], the peripheral benzodiazepine receptor (TSPO) [72], hexokinase II (HKII) [73] and 
several members of the Bcl-2 family. Both pro- and anti-apoptotic BCL-2 family members, 
including BAX, BID, BCL-2 and BCL-XL [74-76] have been shown to physically bind to-
and hence modulate the function of-PTPC components, indicating that the molecular 
machineries mediating MPT-driven and primary MOMP do not operate in a mutually 
exclusive manner. 
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Ca
2+
 ions, prooxidant and proapoptotic proteins, a decrease in the mitochondrial membrane 
potential, pH variations and adenine nucleotides all sensitize the opening of the pore [25, 
77].  
MPT resulting from mPTP opening is usually considered a transducer event in between 
Ca
2+
 or oxidative signal and different type of cell death [78, 79]. 
Recently, we suggested that, similar to PPIF, the c subunit of the FO ATP synthase 
constitutes a critical component of the mPTP and that it is required for the MPT, 
mitochondrial fragmentation and cell death induced by oxidative stress or mitochondrial 
Ca
2+
 overload [21] (discussed later) (Fig. 5). 
 
 
 
Figure 5: Schematic representation of the different components of the mPTP complex. 
 
Nonetheless several observations have suggested that mPTP is a component of the Ca
2+
 
efflux mechanism [80, 81] proposing a physiological role for this ambiguous complex. 
Unfortunately a different amount of studies have proposed the exact opposite [82, 83] 
leaving this supposition still unresolved. 
In this thesis I will focus also my attention on the role of mPTP in mitochondrial Ca
2+
 
homeostasis in a non-pathological context. 
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[Ca
2+
] measurements by the photoprotein Aequorin 
 
At the beginning of the nineties, due to the rapid development of molecular biology 
techniques, the aequorin cDNA was cloned and this opened the possibility to transfect the 
gene and obtain the expression of this protein in live cells. It was then possible to 
specifically localise it within the cell by including defined targeting signals in the amino 
acid sequence to measure variations in [Ca
2+
] in well-defined subcellular compartments in 
a highly specific manner [84]. 
Aequorin was extracted and purified in 1962 by the luminescent jellyfish Aequorea 
Victoria [85]. It consists of a monomeric apoprotein of 189 amino acids and a hydrophobic 
prosthetic group (coelenterazine) of 400 Da. The ability of the bioluminescent protein is 
closely related to the presence of the prosthetic group. The probe has three high affinity 
EF-hand regions able to bind Ca
2+. 
When the cation binds aequorin there is a 
conformational change of the protein resulting in the bond breaking between apoprotein 
and coelenterazine, irreversible oxidation of the latter and photon emission (Fig. 6). In 
nature, the detachment of the prosthetic group in the form of celenteramide is irreversible 
and in vitro an active aequorin can be obtained by incubating the apoprotein with 
coelenterazine in the presence of oxygen and 2-mercaptoethanol. Reconstitution of an 
active aequorin (expressed recombinantly) can be obtained also in living cells by simple 
addition of coelenterazine to the medium. 
 
 
 
 
Figure 6: Scheme of the Ca
2+
 induced photon emission process. 
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The rate of photons emission is measured by a photomultiplier and it can be converted to 
[Ca
2+
]: under known conditions of pH, [Mg
2+
], ionic strength and temperature and 
aequorin exposure to solutions containing known amounts of Ca
2+
 it is possible to draw a 
sigmoidal calibration curve which correlates the [Ca
2+
] with the ratio of light emitted at 
any istant by the photoprotein and measured by the photomultiplier (L) and the light 
emitted from the same aequorin in the presence of saturating [Ca
2+
] (Lmax). [86] (Fig. 7). 
 
 
 
Figure 7: Relationship between the free Ca2+ concentration and the rate of aequorin photon emission 
[86]. 
 
The rate of aequorin luminescence is independent of [Ca
2+
] at very high (>10
-4
 M) and 
very low [Ca
2+
] (< 10
-7
 M). However it is possible to expand the range of [Ca
2+
] that can be 
monitored with aequorin. 
Until now, different recombinant aequorins were obtained, each characterized by a precise 
subcellular localization, by including specific targeting sequencing in the engineered 
cDNAs, and all targeted aequorins synthesized in our laboratory include modifications of 
the photoprotein N-terminal. As demonstrated by Watkins and Campbell in fact, the C- 
terminal proline residue of aequorin is essential for the long-term stability of the bound 
coelenterazine so it is not possible to alterate it [87]. 
It is also possible to introduce a point mutation in one of three sites able to bind Ca
2+
 
(AEQmut) to reduce the affinity of the protein for the cation and thus to obtain accurate 
measurements in a wider range of concentrations (between 1 and 200 μM). Finally, for 
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higher [Ca
2+
] it is possible to use a modified,prosthetic group, the coelenterazine n, which 
has lower affinity for the cation [88]. 
Below I briefly describe the constructs that I used in this thesis. 
 
Cytoplasm (cytAEQ) 
An unmodified aequorin cDNA encodes a protein that, in mammalian cells is located in the 
cytoplasm and, given its small size, also diffuses into the nucleus. An alternative construct 
was also available that is located on the outer surface of the ER and of the Golgi apparatus. 
This construct was intended to drive the localization of aequorin to the inner surface of the 
plasma membrane given that it derives from the fusion of the aequorin cDNA with that 
encoding a truncated metabotropic glutamate receptor (mgluR1). The encoded chimeric 
protein, however, remains trapped on the surface of the ER and Golgi apparatus, with the 
aequorin polypeptide facing the cytoplasmic surface of these organelles. The cytoplasmic 
signal revealed by this chimeric aequorin is indistinguishable from that of a cytoplasmic 
aequorin, but it has the advantage of being membrane bound and excluded from the 
nucleus (Fig. 8). 
 
Mitochondria (mtAEQ)  
All mitochondrial proteins, but the 13 encoded by the organellar genome, are synthesized 
on cytoplasmic ribosomes and then imported into the organelle. In most cases, import 
depends on the presence of a cleavable signal at the N-terminus of a precursor protein. This 
signal (rich in basic and hydroxylated residues, and devoid of acidic ones) usually referred 
to as mitochondrial presequence, is removed after import by matrix proteases [89]. When 
added to a heterologous protein, a mitochondrial presequence is sufficient to drive its 
import into mitochondria. MtAEQ was the first targeted aequorin generated in the 
laboratory, which has been successfully employed to measure the [Ca
2+
] of the 
mitochondrial matrix of various cell types. This construct includes the targeting 
presequence of subunit VIII of human cytochrome c oxidase fused to the aequorin cDNA 
[84] (Fig. 8). 
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Figure 8: Schematic representation of aequorin chimeras. 
 
Luminescence detection 
The aequorin detection system is derived from that described by Cobbold and Lee [90] is 
based on the use of a low noise photomultiplier placed in close proximity (2-3 mm) of 
aequorin expressing cells. The cell chamber, which is on the top of a hollow cylinder, is 
adapted to fit 13-mm diameter coverslip. The volume of the perfusing chamber is kept to a 
minimum (about 200 μl). The chamber is sealed on the top with a coverslip, held in place 
with a thin layer of silicon. Cells are continuously perfused via a peristaltic pump with 
medium thermostated via a water jacket at 37°C. The photomultiplier (EMI 9789 with 
amplifier-discriminator) is kept in a dark box. During manipulations on the cell chamber, 
the photomultiplier is protected from light by a shutter. During aequorin experiments, the 
shutter is opened and the chamber with cells is placed in close proximity of the 
photomultiplier. The output of the amplifier-discriminator is captured by an EMIC600 
photon-counting board in an IBM compatible microcomputer and stored for further 
analysis. 
Recently it has been extensively explained with a specific protocol the subcellular Ca
2+
 
measurements in mammalian cells using aequorin-based probes [91]. 
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MCU involvement in cell cycle 
 
Introduction 
 
Cell cycle, cyclins and cyclin-dependent kinases 
 
Cell division is a universal process for living organisms and it ensures reproduction, 
growth and development of the organism. The regulation of this process is the basis of cell 
ability to maintain genetic integrity, which is important to cell survival and proliferation 
[92]. At present proteins alterations involved in cell cycle regulation are of considerable 
interest, because they are directly involved in the tumor development. Therefore, 
understanding all the mechanisms that regulate cell proliferation becomes increasingly 
indispensable. 
In mammals cell cycle consists of two main phases: interphase and mitosis. The interphase 
occupies most of the time of cell division and can be further divided into:  
- G1 phase, which prepares the cell for the genetic material division with a size increase 
and synthesis of numerous proteins and organelles such as mitochondria and ribosomes. 
At a certain point - the restriction point - the cell is committed to division and moves 
into the S phase. 
- S phase, during which DNA synthesis replicates the genetic material. Each chromosome 
now consists of two sister chromatids. 
- G2 phase, which runs from the completion of S phase until the phase of mitotic 
division. It is characterized by a high metabolic activity and the synthesis of the mitotic 
spindle;  
- G0 phase or "quiescent state” is the phase in which cells do not divide because they are 
already differentiated and do not continue in the division cycle, or it may be a waiting 
phase to proceed the division later. They are busy carrying out their functions in the 
organism. e.g., secretion, attacking pathogens. Most of the lymphocytes in human blood 
are in G0. However, with proper stimulation, such as encountering the appropriate 
antigen, they can be stimulated to reenter the cell cycle at G1. 
The mitotic phase includes the most significant events of cell division and can be 
divided into two phases: mitosis and cytokinesis. During interphase, chromosomes are 
not visible individually but they are condensed in the form of chromatin, an association 
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of DNA and protein present in the nucleus, in the step of division the chromatin coils in 
individual chromosomes that will then be divided. 
The mechanism of division involves the diploid somatic cells (2n): they consist of two 
pairs of homologous chromosomes that carry both genes that control the same 
characteristics.  
A class of proteins directly involved in cell cycle progression are cyclins, discovered in 
1983 by Tim Hunt and his colleagues [93]. Cyclins levels vary drastically through the 
phases of the cell cycle as a result of transcriptional changes and degradation mediated by 
the proteasome. 
There are eight cyclins involved in cell cycle progression: cyclin A1 and A2, B1-B2-B3, C, 
D1-D2-D3, E1-E2, F, G1-G2, H. All these show a 150 amino acid residues region called 
cyclin box; this domain consisting of five helices [94] is responsible for the binding of the 
N-terminal part of specific Cdk [95]. 
The fluctuation of the expression levels of these proteins has been demonstrated by the fact 
that cyclins A and B are accumulated at the beginning of S phase and in the late G2 phase 
respectively, while in G1 phase cyclin D1 levels increase and remain high until the mitosis. 
While cyclins A and B contain a "destruction box", cyclins D and E contain a PEST 
sequence, or a segment of amino acid residues rich in proline (P), glutamic acid (E), serine 
(S) and threonine (T), these sequences are required for efficient proteolysis ubiquitization-
mediated in the end of each phase of the cell cycle [96]. Cyclin H forms complexes with 
Cdk7 to constitute an enzyme known as CAK (kinase activated by Cdk); CAK is involved 
in the activation of CDC2 and Cdk2, respectively, by phosphorylation of residues Thr 160 
and Thr 161. Together with the Cdk 7 and MAT-1 (protein menage-a - trois- 1), cyclin H 
form a tertiary complex which modulates transcription by acting on the activity of RNA 
polymerase II (RNA pol II). Cyclin T does not seem to be directly involved in cell cycle 
regulation, but his bond with the Cdk9 makes active in various processes such as 
transcription, signal transduction and differentiation [95]. 
Cyclin F has some similarities with cyclins A and B, it seems interact with the cyclin B and 
Cdk1 to form a trimeric complex. Cyclins G (G1-G2) are the p53 target and they appear to 
be involved in the arrest of the cycle in G2/M phases after DNA damage.  
Cyclins activate specific Cdks, a family of serine/threonine protein kinases [95], and the 
activation occurs in specific phases of the cell cycle [96]. 
The formation of specific complexes cyclin/Cdk ensures the progression of the cell cycle; 
cyclins have a high expression at particular times and then they are degraded, ensuring the 
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periodic activation of the Cdk, which on the contrary have expression levels constant (Fig. 
9). 
 
 
Figure 9: Schematic representation of the complex cyclin/Cdk during different phases of the cell cycle 
[94]. 
 
So the cell cycle is one of the most regulated mechanisms of the cell.  
It has long been known the role of Ca
2+
 as a second messenger which can be influenced by 
a large number of effector proteins and as explained previously mitochondrial Ca
2+
 
homeostasis is crucial for the destiny of the cell. 
Therefore it was interesting to investigate a possible link between mitochondrial Ca
2+
 
homeostasis and cell cycle. On the other hand, mitochondrial Ca
2+
 uptake by MCU has a 
great importance for the regulation of cell life and energy production. It will be particularly 
interesting to investigate if MCU could be a pivotal regulator of cell cycle. 
After an optimization of synchronization’s protocol for cells derived from primary culture 
(mouse embryonic fibroblast, MEFs), we studied the expression of MCU in different 
phases of cell cycle in synchronized MEFs cells, showing an increased expression of this 
protein in G0 and S-G2 phases. 
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Moreover, we measured mitochondrial and cytosolic Ca
2+
 response after agonist 
stimulation in each phase of cell cycle, and mitochondrial membrane potential, the driving 
force for the Ca
2+
 accumulation within the mitochondria. 
Finally we checked also the effect of MCU overexpression on cell cycle phases. 
Our data show that MCU expression positively correlates with the mitochondrial 
membrane potential but, surprisingly, it also opposite correlates with agonist-dependent 
mitochondrial and cytosolic Ca
2+
 response. MCU overexpression instead does not alter cell 
cycle phases. 
 
Results and discussion  
 
Results 
 
The first step of this work was an optimization of a cellular synchronization protocol to 
correctly discriminate the different phases of the cell cycle in MEFs cells. The 
synchronization procedure is based on the Serum Starvation (0.1% FBS) to allow the cells 
to enter in the stationary phase G0. Then the serum addiction leads the cells to re-enter in 
the cell cycle. The correct synchronization was assessed by western blot, using specific 
markers of the cycle. In particular, Cyclin A is a marker of S-G2 phase (as described 
previously), p27 or Cyclin-dependent kinase inhibitor 1B is a cell cycle inhibitor protein 
that controls the cell cycle progression at G1, phosphohistone H3 (pHH3) is a marker of M 
phase and Skp1 is used as protein loading control. Asynchronous cells were used as control 
and each cellular homogenate was taken together with the corresponding homogenate in 
synchronized cells. (Fig. 10A). 
We have then evaluated endogenous MCU expression in each phase of cell cycle, and we 
use a specific antibody for the protein of interest. In this case and in the next experiments, 
we use only a single control in asynchronous cells, corresponding to the beginning of cell 
cycle in synchronized cells. It seems evident that MCU is more expressed in G0 and S-G2 
phases, and this expression is specific for MCU. Indeed the expression of another 
mitochondrial protein, ATP5A, coding for α-subunit of F1 ATP synthase, does not change 
in different phases of cell cycle (Fig. 10B). 
We also have studied the MCU involvement in cell cycle by the blockade of its 
degradation through the use of MG-132, an inhibitor of the proteasome. We have treated 
MEFs cells with 10 μM MG-132 3 h before the end of each phase of cell cycle. 
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There are no appreciable differences in the markers of cell cycle, but it is evident that 
MCU is not degraded because its expression remains constant during all the phases. With 
these results we deduce that the non-degradation of MCU and therefore its complete 
stabilization has not effect on cell cycle progression (Fig. 10C). 
 
 
 
Figure 10: (A) Western Blot of MEFs cells synchronization. On the left asynchronous MEFs cells are 
used as control. Cyclin A is a marker of S-G2 phases, p27 is a marker of G0-G1 phase, pHH3 is a 
marker of M phase, Skp1 is used as protein loading control. (B) Western Blot of MCU expression in 
cell cycle. (C) Proteasome inhibition by MEFs cells treatment with MG-132 10 μM for 3 h before the 
end of each cell cycle phase.  
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Therefore it is interesting to investigate a possible link between mitochondrial Ca
2+
 
homeostasis and cell cycle. On the other hand, mitochondrial Ca
2+
 uptake by MCU has a 
great importance for the regulation of cell life and energy production. 
Ca
2+
 is in fact a second messenger able to control multiple cellular processes such as gene 
transcription, muscle contraction, cell proliferation [97], learning, memory, fertilization, 
development and secretion [98]. 
The intracellular Ca
2+
 concentration influences signals that control cell cycle progression, 
despite these strong indications, little attention is paid to the role of Ca
2+
 in the cell cycle 
[46]. 
There are a lot of proteins that are modulated by the Ca
2+
 signal, due to its versatility and 
ability to diffuse, as the CaMK, activated by CaM, which are regulators of the G1/S 
transition and regulators of the exit from mitosis [92]; calcineurin also plays a role in 
mediating the entry into G1 phase and the continuation in the S phase [48]. 
In order to carry out its functions, Ca
2+
 undergoes fluctuations that alter its concentration 
during the resting state: normally Ca
2+
 ions are stored in mitochondria, ER and Golgi 
Apparatus and only in response to stimulation they are released to be poured into the 
cytosol. Mitochondrial and ER networks are also fundamental for the maintenance of 
cellular homeostasis and for the determination of cell fate under stress conditions [34]. The 
communication between the two organelles takes place via a zone of close contact between 
ER and mitochondria, called MAM [35], involved in bioenergetics and cell survival. 
In particular, ER is constituted by a network of connections between cisterns and tubular 
structures that represent an extension of the nuclear envelope. During the cell cycle this 
structure undergoes specific changes: during interphase it is presented as a series of tubules 
and cisterns, while at the time of mitosis, it only highlights the extensive network of 
cisterns. This alteration is due to the depolymerization of microtubules that occurs during 
the M phase; once anaphase occurred, cisterns are able to provide the making of the 
nuclear envelope, even before the appearance of the tubular structure [99]. 
For [Ca
2+
] measurements in different
 
intracellular compartments, we infected MEFs cells 
with the adenovirus for the mitochondrial and cytosolic aequorin. This experiment was 
conducted in asynchronous and synchronized cells. MEFs cells are stimulated with 100 μM 
ATP to enable Ca
2+
 mobilization. This agonist selectively binds the membrane receptor 
coupled to a trimeric G protein: in particular, the α subunit is able to activate 
phospholipase C which hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) 
generating diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). The IP3 binding to 
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its receptor on the ER causes an increase of the [Ca
2+
] in the cytoplasm and in the 
mitochondrial matrix. 
So [Ca
2+
]m measured after agonist stimulation is 37.33 ± 1.68 μM in asynchronous cells, 
28.76 ± 2.85 μM in G0 phase cells, 32.4 ± 2.57 μM in G1 phase cells, 58.17 ± 4.33 μM in 
G1/S phase cells, 50.12 ± 4.13 μM in S phase cells, 48.44 ± 8.09 μM in G2 phase cells and 
65.0 ± 6.86 μM in M phase (n=15). (Fig. 11A and 11B) 
Instead [Ca
2+
]c measured after agonist stimulation is 2.27 ± 0.11 μM in asynchronous cells, 
1.65 ± 0.1 μM in G0 phase cells, 2.41 ± 0.09 μM in G1 phase cells, 1.97 ± 0.08 μM in 
G1/S phase cells, 1.97 ± 0.08 μM in S phase cells, 1.77 ± 0.06 μM in G2 phase cells and 
1.95 ± 0.07 μM in M phase (n=15). (Fig. 11C and 11D) 
Our data suggest that, surprisingly, MCU expression opposite correlates with agonist-
dependent mitochondrial and cytosolic Ca
2+
 response. 
 
 
 
Figure 11: Measurements of [Ca
2+
] using recombinant aequorin upon agonist (100 μM ATP) 
stimulation in mitochondria (A and B) and cytosol (C and D) in MEFs cells. The data are presented as 
means ± SEM *p<0.05, ***p<0.001. 
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We then questioned about the possible effect of the phase-specific expression of MCU on 
the mitochondrial membrane potential (Ψm), since it represents the driving force for the 
Ca
2+
 accumulation within mitochondria. To measure this parameter we use the fluorescent 
probe Tetramethylrhodamine, methyl ester (TMRM), a cell-permanent, cation, red-orange 
fluorescent dye that is readily sequestered by active mitochondria, in asynchronous and 
synchronized MEFs cell. 
The percentage of arbitrary fluorescence units (AFU) measured are -42.37 ± 1.72 in 
asynchronous cells, -43.27 ± 1.82 in G0 phase cells, -42.1 ± 1.79 in G1 phase cells, -28.08 
± 1.46 in G1/S phase cells, -32.38 ± 1.29 in S phase cells, -38.31 ± 1.74 in G2 phase cells 
and -31.35 ± 1.28 in M phase (n=80) (Fig.12). 
Our data show that MCU expression in this case positively correlates with the 
mitochondrial membrane potential. 
 
 
 
Figure 12: Measurements of ΔΨm with potentiometric dye TMRM in MEFs cells. The data are 
presented as means ± SEM *p<0.05, **p<0.01, ***p<0.001. 
 
To evaluate the possible role of MCU in cell cycle, we decided to investigate the effects of 
its overexpression in the different phases.  
The overexpression was achieved by cells infection with an adenovirus expressing MCU. 
Cell cycle was analyzed by the Tali® Image-Based Cytometer and we meausured control 
cells without infection (Fig. 13A), cells infected with an adenovirus expressing a 
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mitochondrial Green Fluorescent Protein (mtGFP) (Fig. 13B) and cells expressing MCU-
GFP (Fig. 13C). 
 
  
Not infected 
 PHASE  % CELLS 
 G1 phase  65% 
 S phase  5% 
 G2-M phase  30% 
 
 
mtGFP infection 
 PHASE  % CELLS 
 G1 phase  62% 
 S phase  7% 
 G2-M phase  31% 
 
 
MCU-GFP infection 
 PHASE  % CELLS 
 G1 phase  63% 
 S phase  7% 
 G2-M phase  29 
 
 
Figure 13: Cell cycle analysis in not incedcted (A), mtGFP infected (B) and MCU-GFP infected (C) 
MEFs cells by Tali® Image-Based Cytometer. The percentage of cells is referred to the number of cells 
in each phase of cell cycle. 
 
MCU overexpression does not alter cell cycle progression, as the percentage of cells in 
each phase of cell cycle does not change. 
The effects of MCU overexpression were also evaluated by use of FACS (Fluorescence-
Activated Cell Sorting), which has a high sensitivity and precision and it is perfectly 
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indicated for this type of analysis. As for the previous experiment, we meausured control 
cells without infection (Fig. 14A), cells infected with an adenovirus expressing mtGFP 
(Fig. 14B) and cells expressing MCU-GFP (Fig. 14C).  
  
 
 
Figure 14: Cell cycle analysis in not incedcted (A), mtGFP infected (B) and MCU-GFP infected (C) 
MEFs cells by FACS. The percentage of cells is referred to the number of cells in each phase of cell 
cycle. 
 
These results confirm our previous data, the overexpression of MCU does not seem to 
affect cell cycle. Minor variations in cellular distribution are present only between infected 
and not infected cells, maybe due to the cell transfection. 
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Discussion 
 
The cell cycle is the series of events leading to cell division and duplication of its genetic 
material. It is an evolutionarily conserved process in the succession of the events and in 
their regulation [95]. 
The proper development of an organism is due to the precise regulation and the respect of 
the order of cell cycle progression. Proteins alterations can trigger an uncontrolled 
proliferation that often leads to tumor formation, thus it is so important that all the events 
of the cycle are regulated on multiple levels. 
The control system is constituted by the complex cyclin/Cdk. Cyclins are proteins with 
different expression in the cell cycle phases, as a result of transcriptional changes and 
proteasome degradation [96]. 
Cdks are a family of serine/threonine protein kinase that form specific complexes with 
cyclins and ensure the cell cycle progression. In fact cyclins expression in well-determined 
phases allows the periodic activation of the Cdk that, instead, show constant levels of 
expression [96]. 
A lot of Ca
2+
-binding proteins (CaM, CaMK and calcineurin) are involved in the regulation 
of certain phases of the cell cycle [47]. Recently, it has been identified the mitochondrial 
Ca
2+
 uniporter MCU, a protein of 40 kDa expressed in all tissues, which is located in the 
IMM, with the N-terminal and the C-terminus facing the matrix [40, 41]. MCU is a low 
affinity-channel but it has been shown that mitochondria are exposed to microdomains 
with high [Ca
2+
], which represent the contact sites between mitochondria and ER [100]. 
Given the high importance of this protein in the regulation of cell life, the aim of this work 
is the investigation of a possible MCU involvement in the cell cycle. At the beginning the 
attention was focused on the development of cell cycle synchronization protocols for 
primary cultures (MEFs cells) in order to discriminate the different phases of the cycle.  
We then evaluate endogenous expression of MCU in each phase of the cell cycle by 
western blot. MCU is more expressed in G0 and S-G2 phases, and this is specific for the 
protein of interest as the expression of another mitochondrial protein, ATP5A, coding for 
α-subunit of F1 ATP synthase, does not change in different phases of cell cycle. 
We also have investigated the MCU involvement in cell cycle by the blockade of its 
degradation through the use of MG-132, an inhibitor of the proteasome. It is evident that 
MCU is not degraded because its expression remains constant during all the phases. We 
can deduce that the non-degradation of MCU and therefore its complete stabilization has 
not effect on cell cycle progression. 
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At this point, given the important role of the MCU in the Ca
2+ 
homeostasis, we measured 
mitochondrial and cytosolic Ca
2+
 concentrations after agonist stimulation in each phase of 
cell cycle, so as to be able to understand if the phase-specific expression of MCU is related 
to a different Ca
2+
 accumulation into mitochondria. Surprisingly, MCU expression 
opposite correlates with agonist-dependent mitochondrial and cytosolic Ca
2+
 response. 
The Ca
2+
 accumulation gradient into mitochondria is governed by the strongly 
electronegative potential inside so we proceeded with mitochondrial membrane potential 
measurement in the different phases of the cell cycle. To measure this parameter we use 
the fluorescent probe TMRM, a cell-permanent, cation, red-orange fluorescent dye that is 
readily sequestered by active mitochondria, in asynchronous and synchronized MEFs cell. 
Data reveal a positive correlation with the phase-specific expression of the MCU, 
suggesting a compensatory effect of the expression of the protein of interest. 
At this point, it was interesting to understand if MCU overexpression could have influence 
on cell cycle progression and we took advantage of the use of flow cytometry, in particular 
a specialized type of this technology, the fluorescence-activated cell sorting (FACS). It 
provides fast, objective and quantitative recording of fluorescent signals from individual 
cells as well as physical separation of cells in each phase of cell cycle. 
MEFs cells were infected with an adenovirus expressing mtGFP or with an adenovirus 
expressing MCU-GFP, cells not infected were used as control. The percentage of cells in 
each phase of the cell cycle remains constant in all the experimental conditions, to indicate 
that the overexpression of MCU does not alter cell cycle progression. 
Numerous other works are still in progress and not included in this thesis.  
We are trying to modulate the mitochondrial membrane potential using two compounds 
known for their ability to alter it. The first one is FCCP (Carbonyl cyanide -p- 
trifluoromethoxyphenylhydrazone), a chemical uncoupler of electron transport and 
oxidative phosphorylation, that permeabilizes the IMM to protons, destroying the proton 
gradient and, in doing so, uncouples the electron transport system from the oxidative 
phosphorylation system. Thus electrons continue to pass through the electron transport 
system and reduce oxygen to water, but ATP is not synthesized in the process. 
The second compound is the methyl succinate, a putative cell permeable complex II-linked 
substrate that, on the contrary, hyperpolarizes the mitochondrial membrane.  
We are also investigating the correlation between cell cycle, MCU and cancer: it is known 
that miR-25 (a microRNA overexpressed in colon cancer cells) decreases mitochondrial 
Ca
2+
 uptake through selective MCU downregulation, conferring resistance to apoptotic 
challenges. MCU appears to be downregulated in human colon cancer samples, and 
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accordingly, miR-25 is aberrantly expressed, indicating the importance of mitochondrial 
Ca
2+
 regulation in cancer cell survival [56]. Therefore it is evident that MCU has a great 
importance in the regulation of cell fate and for this reason we are moving on a tumor cell 
line.  
In conclusion, these experimental evidences suggest that the only activity of MCU is not 
sufficient for the regulation of the cell cycle.  
In the light of the latest discovery about the different components of the uniporter complex 
[54, 59, 60, 62, 63], it is now interesting to investigate the possible involvement of these 
proteins in cell cycle, and preliminary data show that also in this case there is a different 
phase-specific protein expression. Our data suggest moreover that MCU could have a 
possible compensatory role in mitochondrial Ca
2+
 homeostasis.  
Future experiments will then be directed to study the roles of all MCU’s interactors in the 
cell cycle progression, with a more thorough investigation in tumor cell line. 
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Role of the c subunit of the Fo ATP synthase in mitochondrial 
permeability transition 
 
Introduction 
 
MPT refers to an alteration in the permeability of the IMM; the MPT was first 
characterized in 1979 [101] and then linked to cell death [102].  
More recently, it was hypothesized that the permeability transition state is caused by a high 
permeability channel [103] termed the mPTP. Several studies have examined the molecular 
structure of the pore and revealed its complex organization, which includes proteins 
located in all of the mitochondrial sub-districts. Although all of these elements exhibit 
regulatory activity, a complete model for mPTP activity is lacking. Some proteins formerly 
believed to be crucial for PTP, have been excluded after experiments with the use of 
transgenic knockout animals, is the case of the ANT [104], and VDAC [105]. Several lines 
of evidence suggest that mitochondrial ATP synthase is linked to mPTP. Specifically, i) a 
selective inhibitor of mitochondrial ATP synthase, oligomycin, is able to prevent MPT and 
cell death induced by TNF-alpha [106], staurosporine [107] or pro-apoptotic Bax protein 
[108]; ii) both mPTP and ATP synthase display sensitivity to Mg
2+ 
[109, 110] and iii) 
cyclophilin D, a fundamental regulator of mPTP [111, 112] interacts with the lateral stalk 
of ATP synthase and regulates its activity [113], similar to the cell death and mPTP 
regulator Bcl-xL [114]. Here, we demonstrate that the c-subunit of mitochondrial ATP 
synthase is present in mPTP and plays a determinant role in MPT activity. This finding 
suggests that the c-subunit plays a direct role in the core-forming element of mPTP, thus 
establishing the c-subunit as an important player in the processes of crucial 
physiopathological relevance. 
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Results and Discussion 
 
The FO portion of ATP synthase requires 3 different subunits for its proton pumping 
activity: a, b and c [115]. A-subunit is encoded by the mitochondrial DNA, while b- and c-
subunits are encoded by nuclear DNA. Recently, mPTP opening activity has been 
demonstrated in cells deprived of mitochondrial DNA, indicating that a-subunit does not 
participate in mPTP opening [116]. Conductive properties have been indicated for c-
subunit [117] but not for b-subunit. In addition, a peptide with a high level of similarity to 
c-subunit has been proposed as a regulator of mPTP [118]. Thus, we focused our attention 
to c-subunit. 
The MPT perturbs several aspects of mitochondrial physiology by inducing a decrease in 
ΔΨm, the release of mitochondrial proteins, network fragmentation, and impaired Ca
2+
 
uptake in the mitochondrial matrix. The manipulation of c-subunit levels was thus 
expected to impair several of these features if it is involved in mPTP. C-subunit is encoded 
by ATP5G1, 2 and 3. Each gene possesses a different mitochondrial targeting sequence 
that is cleaved by matrix peptidases to generate the same mature protein [119]. We used a 
mixture of siRNAs directed against the three isoforms of the c-subunit to down-regulate 
the levels of c-subunit protein (Fig. 15B) and a vector expressing ATP5G1 cDNA to 
increase c-subunit levels (Fig. 15A and 15B). We measured ATP levels within the 
mitochondrial matrix using recombinant mitochondrial targeted firefly luciferase (mtLuc) 
as previously described [120]. In the presence of luciferin, HeLa cells expressing mtLuc 
emit light proportionally to [ATP] in the mitochondrial matrix ([ATP]m). ATP production 
can be stimulated by a transient increase in [Ca
2+
]m, which promotes the activity of the 
Krebs cycle. In our cell model, histamine-induced Ca
2+
 uptake within mitochondria 
resulted in a slight increase in luminescence (Fig. 15Ci); this is to be expected in HeLa 
cells, which do not rely heavily on respiration [120]. The simultaneous silencing of all 3 c-
subunit isoforms did not induce much variation in ATP levels, confirming the glycolytic 
nature of the chosen cell model. Overexpression of the c-subunit magnifies this increase, 
indicating more efficient ATP synthesis (Fig. 15Cii). Together with the increase in ATP 
levels, c-subunit overexpression led also to a reduction in ΔΨm, as revealed by TMRM 
staining (Fig. 15Di) due to ATP synthesis-related depolarization (state 3 of respiration). 
Under these conditions, mitochondrial Ca
2+
 uptake can be monitored through the use of 
recombinant aequorin. C-subunit silencing induced only a weak, non-significant reduction 
in ΔΨm (Fig. 1Dii), this was likely due to the regulatory effects of c-subunit silencing on 
respiratory chain complexes, as previously demonstrated [121]. 
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An analysis of mitochondrial morphology using 3D imaging deconvolution in HeLa cells 
expressing mtGFP indicated that c-subunit overexpression promotes network 
fragmentation, which was manifested as a large increase in the number of objects 
composing the mitochondrial network (Fig. 15E). This result suggests that c-subunit 
overexpression-related increase in the rate of ATP production dictates mitochondrial 
morphology [122]. On the other hand, c-subunit silencing did not induce relevant 
alterations in the network morphology (Fig. 15E). The effect on mitochondrial number is 
not due to variations in the total mitochondrial mass as indicated by western blotting for 
the mitochondrial VDAC, ATP synthase a-subunit, ATP synthase alpha-subunit and 
cytochrome c levels, which do not correlate with c-subunit levels (Fig. 15B). 
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Figure 15: (A) Colocalization between overexpressed c-subunit encoding plasmid (red) and the 
mitochondrial marker HSP60 (green). (B) Immunoblot analysis of mitochondrial proteins in HeLa 
cells, transfected with scrambled siRNA, c-subunit encoding plasmid or siRNA ATP5G1, 2, 3. (C) 
Effect of histamine agonist on [ATP]m measured by using mitochondrial targeted luciferase construct 
(mtLuc) in scrambled-transfected and ATP5G1, 2, 3 silenced HeLa cells (Ci) and mock-transfected, c-
subunit overexpressing (Cii). Luminescence data are expressed as a percentage of the initial value. (D) 
Basal intensity of TMRM loaded HeLa cells during c-subunit overexpression (Di) or siRNA ATP5G1, 
2, 3 (Dii). (E) Analysis of mitochondrial structure in HeLa cells co-transfected with a green fluorescent 
protein targeted to mitochondria (mtGFP) together with scrambled siRNA or siRNA ATP5G1, 2, 3 or 
c-subunit encoding plasmid. Data represent mean ± SEM of mitochondrial number. *p<0.05.  
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The manipulation of c-subunit levels has more significant effects when mPTP opening is 
induced. To monitor the live opening of the mPTP, we used the calcein-cobalt assay with 
our cell model system. Calcein generates common cytoplasmic staining in the absence of 
cobalt. When cobalt is added, cytosolic calcein is quenched whereas mitochondrial calcein 
is protected due to the impermeability of the IMM [123]. The stimulation of the MPT by 1 
μM ionomycin permits cobalt entry into the mitochondrial matrix, which quenches 
mitochondrial calcein at a very high rate (Fig. 16A). If the cells are exposed to 1 μM 
Cyclosporine A (CsA), the rate of calcein quenching is drastically reduced. The inhibition 
of the calcein quenching rate by c-subunit silencing was similar to that which was induced 
by CsA exposure (Fig. 16A), while c-subunit overexpression dramatically increased the 
quenching rate compared with mock transfected cells (Fig. 16B). Within 10 min of 
exposure to ionomycin, calcein was typically completely quenched whereas CsA almost 
completely prevented this phenomenon (Fig. 16B). 
We then analyzed the mitochondrial morphology alterations under the same conditions, a 
process that was previously demonstrated to be dependent on mPTP activity [29]. The 
mitochondrial networks were dramatically fragmented after ionomycin treatment, reaching 
a maximal fragmentation after 10 min (Fig. 16C). This phenomenon was significantly 
inhibited in CsA-pretreated cells and after c-subunit silencing (Fig. 16C). On the contrary, 
cells overexpressing the c-subunit displayed a faster and more extensive network 
fragmentation (Fig. 16D). 
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Figure 16: (A) Representative Calcein assay during ionomycin 1 M (Iono) induced mPTP opening in 
cells transfected with scrambled siRNA or siRNA ATP5G1, 2, 3 and (B) after transfection with mock 
or c-subunit encoding plasmid. CsA 1 M was used as negative control. (C) Time course of 
mitochondrial fragmentation in HeLa cells expressing mtGFP following ionomycin 1 M induced 
mPTP opening. Fragmentation was monitored for 30 min in cells co-trasfected with scrambled siRNA 
or siRNA ATP5G1, 2, 3. (D) Time-laps were reduced to 10 min in HeLa transfected with mock or c-
subunit encoding plasmid. Where indicated, before experiments, cells were treated with CsA 1 M for 
30min. Data represent mean ± SEM *p<0.05. 
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Mitochondria transfected with a control siRNA and exposed to high dose of the prototypic 
pro-oxidant hydrogen peroxide H2O2 underwent an irreversible depolarization. The ΔΨm of 
cells depleted of the Fo c subunit dissipated upon the administration of high-dose H2O2 
with a delayed kinetics (Fig. 17A). As expected, cells overexpressing the c-subunit also 
depolarized dramatically faster also at low concentrations of H2O2 (Fig. 17B).  
Prolonged MPT has been demonstrated as an event linked to the release of mitochondrial 
proteins preceding different types of cell death [26]. 
A cytosol isolation experiment in which digitonin was used to permeabilize the plasma 
membrane without disrupting mitochondrial integrity indicated that cytochrome c release is 
inducible by H2O2 in cells transfected with scrambled siRNA, but this process was strongly 
inhibited by c-subunit silencing (Fig. 17C).  
H2O2- and ionomycin-induced cell death (as measured by PI positivity) was dramatically 
inhibited by c-subunit silencing (Fig. 17D), whereas simple overexpression of the c-
subunit was able to induce an increase in PI positivity in untreated cells that was further 
dramatically increased by H2O2 exposure compared with mock-transfected cells (Fig. 
17E). 
Mitochondrial ATP synthase activity is closely linked to the amount of regulators of mPTP 
opening such as ADP and inorganic phosphate (Pi). The specific effects of these elements 
on pore opening are still a matter of intense debate [69, 124]; nonetheless, the indirect 
modulation of the mPTP by the impairment of ATP synthase activity could be expected.  
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Figure 17: (A) Representative TMRM assay during hydrogen peroxide (H2O2) induced mPTP opening. 
H2O2 was used at 2 mM concentration in cells transfected with scrambled siRNA or siRNA ATP5G1, 2, 
3 or (B) at 500 M during transfection with mock or c-subunit encoding plasmid. (C) Cytosolic 
extracts from HeLa cells showing amounts of cytochrome c (Cyt. c) released from mitochondria, after 
apoptotic induction (H2O2 1 mM, 2h), in scrambled-transfected and ATP5G1, 2, 3 silenced HeLa cells. 
(D) Percentage of PI positive cells after treatment with H2O2 1 mM and ionomycin 10 μM in scrambled 
siRNA or a siRNA ATP5G1, 2, 3 transfected cells referred to untreated scrambled transfected cells. (E) 
Percentage of PI positive cells after treatment with H2O2 1 mM and ionomycin 10 μM in c-subunit 
overexpressing cells referred to untreated mock-transfected cells. (F) Extent of cell death in neurons 
co-trasfected with GFP and scrambled siRNA (Fi) or siRNA ATP5G1, 2, 3 (Fii) upon excitotoxicity 
challenge. (G) PI intensity was measured only in nuclei of GFP positive cells (indicated by the white 
arrows in representative images). Data represent mean ± SEM *p<0.05. 
 48 
To avoid this misinterpretation, we silenced the α-subunit of mitochondrial ATP synthase, 
which is mainly involved in the organization of the F1 portion and contains nucleotide-
binding sites that are fundamental for the catalysis of ATP synthesis [125]. As previously 
demonstrated for c-subunit silencing, α-subunit siRNA (Fig. 18A) did not significantly 
impair ATP synthesis in HeLa cells (Fig. 18B). However, while c-subunit depletion 
severely impaired mPTP opening, α-subunit depletion did not alter the rate of calcein 
quenching (Fig. 18C) or the network fragmentation induced by ionomycin (Fig. 18D). 
Finally, HeLa cells transfected with α-subunit siRNA and exposed to H2O2 or ionomycin 
displayed the same level of PI positivity as HeLa cells transfected with scrambled siRNA 
(Fig. 18E). Overall these data indicate that c-subunit manipulation directly impairs mPTP 
as opposed to causing secondary effects due to the alteration of mitochondrial ATP 
synthase activity. 
To further demonstrate the functionality of the c-subunit as a strategic element in the 
mPTP and MPT-induced cell death, we examined a more complex and physiologically 
relevant system. Glutamate-induced neurotoxicity is dependent on mPTP opening [126], 
and mitochondrial physiology has become a focus of research for several 
neurodegenerative diseases. Glutamate induces Ca
2+
 entry from the extracellular milieu, 
causing [Ca
2+
]m overload and the MPT during excitotoxicity [127]. When cultured rat 
neurons stained with TMRM were exposed to 500 μM glutamate (Fig. 18F), progressive 
mitochondrial depolarization was detectable in 64% of cells; however, only 50% of c-
subunit-silenced cells displayed depolarization (Fig. 18Fi). Moreover, depolarization 
occurred at a significantly lower rate in silenced neurons (Fig. 18Fii). To examine the 
extent of excitotoxicity after 30 min of exposure to glutamate, the neurons were washed 
and allowed to recover for 24 h prior to staining with PI. PI intensity, as detected by 
fluorescence microscopy, appeared significantly higher in neurons transfected with 
scrambled siRNA compared to those transfected with siRNAs targeting ATP5G1, 2, and 3 
indicating that c-subunit is fundamental for glutamate-induced excitotoxicity and the MPT 
in neuronal cells (Fig. 18G).  
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Figure 18: (A) HeLa cells were transfected for 48 hours with either scrambled or siRNA ATP5A1. Cells 
were harvested, total proteins were extracted and endogenous -subunit was detected by western 
blotting using MitoProfile Total OXPHOS Human Antibody Cocktail. Actin was blotted as loading 
control. (B) Effect of histamine agonist on [ATP]m measured by using mitochondrial targeted 
luciferase construct (mtLuc) in scramble-transfected and -subunit silenced HeLa cells. Luminescence 
data are expressed as a percentage of the initial value. (C) Calcein assay during ionomycin 1 M (Iono) 
induced mPTP opening in cells transfeted with scrambled siRNA or siRNA ATP5A1. (D) 
Mitochondrial number, as deduced by calculating object number. HeLa cell were transfected with a 
green fluorescent protein specifically targeted to the mitochondria (mtGFP), scrambled siRNA, or 
siRNA ATP5A1. Images were acquired at the indicated time points before and after treatment with 
ionomycin. (E) Percentage of PI positive cells after treatment with H2O2 1 mM and ionomycin 10 M 
in scrambled siRNA or a siRNA ATP5A1 transfected cells referred to untreated scrambled transfected 
cells. Data represent mean ± SEM *p<0.05. 
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Overall, these data indicate that the c10 ring of the mitochondrial ATP synthase is a key 
player in the MPT and strongly suggest that it participates in the core-forming element of 
the mitochondrial permeability transition pore also on the light that, in vesicles enriched in 
F1FO ATP synthase [114], a regulated non-selective leak conductance, sensitive to ATP 
and increased by pharmacological or genetic inhibition of Bcl-xL has been recorded.  
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The mitochondrial permeability transition pore is a dispensable 
element for mitochondrial calcium efflux 
 
Introduction 
 
Mitochondria are intracellular organelles involved in several cellular functions such as 
ATP production, fatty acid oxidation, Ca
2+
 signaling and cell death [36, 78, 128]. Under 
pathological conditions, mitochondria are able to adapt by fusion or fission processes and 
modulate respiratory substrate utilization to regulate ATP production [15]. Furthermore, in 
cases of severe damage, mitochondria are eliminated by autophagy, and cell death can 
occur [129]. Thus, these organelles are master regulators of danger signaling [130, 131]. 
A key signaling messenger that is able to transduce life or death signals to mitochondria is 
intracellular Ca
2+
 [38, 132]. The mitochondrial Ca
2+
 uptake and release mechanisms are 
based on the utilization of gated channels for Ca
2+
 uptake and exchangers for release that 
are dependent upon the negative m, which represents the driving force for Ca
2+
 
accumulation in the mitochondrial matrix [39]. MCU, which is encoded by the recently 
discovered gene ccdc109a [40, 41], is responsible for Ca
2+
 influx, while NCLX [42] is 
responsible for Ca
2+
 efflux. In spite of this information, the mitochondrial Ca
2+
 efflux 
mechanism has not been completely elucidated. It is mostly accepted that Na
+
/Ca
2+ 
exchange activity is relevant for excitable cells [43] and that NCLX inhibition or silencing 
does not completely arrest Ca
2+
 efflux [42], which indicates that other mechanisms are 
involved in this process. Two mechanisms have been proposed to supplement Ca
2+ 
efflux, 
one based on the H
+
/Ca
2+ 
antiporter [44] and another based on the mPTP [45], but evidence 
supporting the latter remains elusive. 
The mPTP is a high-conductance channel that is located at the contact sites between the 
inner and outer mitochondrial membranes. This channel is responsible for the non-selective 
permeability state of the mitochondrial inner membrane. The transition to this state for 
small molecules is referred to as the MPT. The molecular composition of the mPTP is not 
yet clear, but several proteins have been shown to be components that participate in mPTP 
activity, including VDAC [67], ANT [68], PiC [69], PPIF [70, 71], TSPO [72], HKII [73] 
and several members of the Bcl-2 family [74, 76, 133]. 
Ca
2+
 ions, prooxidant and proapoptotic proteins, a decrease in the mitochondrial membrane 
potential, pH variations and adenine nucleotides all sensitize the opening of the pore [25, 
77].  
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MPT resulting from mPTP opening is usually considered a transducer event in between 
Ca
2+
 or oxidative signal and different type of cell death [78, 79]. Nonetheless several 
observations have suggested that mPTP is a component of the Ca
2+
 efflux mechanism [80, 
81, 134, 135] proposing a physiological role for this ambiguous complex. Unfortunately a 
different amount of studies have proposed the exact opposite [82, 83] leaving this 
supposition still unresolved. Therefore, we focused on the role of the mPTP in 
mitochondrial Ca
2+
 homeostasis under non-pathological conditions. Recently, we 
suggested that, similar to PPIF, the c subunit of the FO ATP synthase constitutes a critical 
component of the mPTP and that it is required for the MPT, mitochondrial fragmentation 
and cell death induced by oxidative stress or mitochondrial Ca
2+
 overload [21]. A concept 
further confirmed by two different groups [136, 137]. 
By modulating c subunit expression and using pharmacological approaches, we revealed 
the important finding that the mPTP is not necessary for mitochondrial Ca
2+
 release; 
therefore, it does not participate in mitochondrial Ca
2+
 homeostasis in a non-pathological 
context at least in HeLa cells. 
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Results and discussion 
 
Results 
 
To study the contribution of mPTP in mitochondrial Ca
2+
 homeostasis, we have 
investigated the kinetics of the mitochondrial and cytosolic Ca
2+ 
influx and efflux. We 
have recently suggested that the c subunit of the FO ATP synthase is a component of the 
mPTP that is required for the MPT-driven mitochondrial fragmentation that is induced by 
cytosolic Ca
2+
 overload and oxidative stress [21]. Therefore, we decided to modulate 
mPTP activity by genetically manipulating the expression of the c subunit in the HeLa 
human cervical carcinoma cell line. The mammalian ATP synthase c subunit is encoded by 
three different nuclear genes (ATP5G1, ATP5G2 and ATP5G3) that produce three 
different proteic products. These products differ in their mitochondrial localization 
sequence, but results in the same mature protein after cleavage of the localization peptide 
[121]. As previously shown, we used a mix of three commercially validated small-
interfering RNAs (siRNAs) to silence the three different genes that code for the c subunit 
(ATP5G1, ATP5G2 and ATP5G3). Analysis of mRNA levels for the three genes by Real 
Time PCR indicates that silencing strategy produces an approximate reduction of 75 % for 
ATP5G1, 53 % for ATP5G2 and 20 % for ATP5G3 (Fig. 19Ai). This also results in a 
reduction close to 70 % of total protein levels as indicated by western blot analysis (Fig. 
19Aii). To monitor the effective state of the mPTP, we used the calcein-Co
2+
 assay during 
c subunit silencing (Fig. 19B). As previously reported, ATP5G silencing ablated the mPTP 
activity and resulted in increased fluorescence of mitochondrial calcein (Fig. 19C). 
By taking advantage of aequorin technology [91], we first measured the mitochondrial and 
cytosolic Ca
2+
 concentrations after stimulation with 100 M histamine in HeLa cells that 
were transfected with a control siRNA (siSCR) or a mix of siRNAs that targeted ATP5G1, 
ATP5G2 and ATP5G3 (siATP5G) for 48 h (Fig. 19C). Silencing of the c subunit 
[siATP5G] caused a non-significant reduction in Ca
2+
 uptake by the mitochondria (peak 
amplitude: 67.35 ± 4.41 M vs. 71.08 ± 3.33 M [siSCR]; p > 0.05) and in the Ca2+ uptake 
rate, but no significant variations in the rate of Ca
2+
 release from the mitochondria (Fig. 
19D). Further no significant differences in the cytosolic Ca
2+
 levels (peak amplitude: 2.13 
± 0.09 M vs. 2.32 ± 0.08 M [siSCR]; p > 0.05) (Fig. 19E) or in the kinetics of Ca2+ 
influx and efflux (Fig. 19F) were detected. 
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Figure 19: Calcium signaling during F1/FO ATP synthase c subunit silencing in HeLa cells. The 
mRNA relative aboundance of ATP5G1, ATP5G2 and ATP5G3 (Ai) and the protein relative 
aboundance of ATP5G (Aii) after Human cervical carcinoma (HeLa) cells transfection with a 
scrambled siRNA (siSCR) or a mix of siRNAs targeting ATP5G1, ATP5G2 and ATP5G3 (siATP5G) 
for 48 h. Fluorescence intensity levels in the Calcein-Co
2+
 assay (B). HeLa cells were transfected as in 
(A) but in a combination with a plasmid encoding a mitochondrial red fluorescent protein (mtDsRED). 
These cells were monitored using fluorescence microscopy to assess the Calcein signal.  
HeLa cells were transfected as in (A) but in a combination with a plasmid coding for a mitochondrial 
(C) (n=30 from 6 indipendent experiments) or cytosolic (E) (n=10 from 3 indipendent experiments) 
aequorin and then stimulated with 100 μM histamine (Hist). 
The rates of mitochondrial (D) and cytosolic (F) Ca
2+
 accumulation and release and a schematic 
representation of the meaning of the indexes are shown. The data are presented as means ± SEM *p < 
0.05,***p < 0.001. 
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To confirm the experimental method, mitochondrial Ca
2+
 dynamics were monitored in the 
presence of a well-established blocker of the mitochondrial Ca
2+
 efflux system, 
CGP37157, which is an inhibitor of the mitochondrial Na
+
/Ca
2+
 exchanger [138]. 
HeLa cells were exposed to CGP37157 (10 M) for 2 min, and Ca2+ uptake was induced 
with histamine (100 M) in the continuous presence of the inhibitor. 
CGP37157 caused an expected increase in Ca
2+
 uptake by the mitochondria (peak 
amplitude: 109.2 ± 15.52 μM vs. 68.6 ± 6.81 μM [MOCK]; p < 0.05) (Fig. 20A) and a 
significant decrease of 31% in the rate of Ca
2+
 release from the mitochondria due to 
inhibition of the mitochondrial Na
+
/Ca
2+
 exchanger (Fig. 20B). The absence of significant 
differences between the cytosolic Ca
2+
 levels (peak amplitude: 2.84 ± 0.06 μM vs. 2.77 ± 
0.33 μM [siSCR]; p > 0.05) (Fig. 20C) and Ca2+ influx and efflux kinetics (Fig. 20D) 
confirmed the specificity of CGP37157. 
 
 
Figure 20: Inhibition of mitochondrial Ca
2+
 efflux by CGP37157. HeLa cells were transfected with a 
plasmid coding for a mitochondrial (A and B) (n=9 from 3 indipendent experiments) or cytosolic (C 
and D) (n=9 from 3 indipendent experiments) aequorin and treated with 10 μM CGP37157 for 2 min. 
The cells were then stimulated with 100 μM histamine (Hist) in the continuous presence of the 
inhibitor (A and C). Rates of mitochondrial (B) or cyctosolic (D) Ca
2+
 accumulation and release. The 
data are presented as means ± SEM *p < 0.05, **p<0.01. 
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In our experimental settings, HeLa cells appear to display higher RNA levels of ATP5G1 
compared to its omologous. We thus decided to overexpress a Myc-tagged ATP5G1, 
which was under the control of the cytomegalovirus immediate early promoter and verify 
its effect on mitochondrial calcium homeostasis. 
Overexperession levels were assessed by western blot and results in dramatic increase in 
levels of c subunit (Fig. 21A). As expected, ATP5G1 overexpression was sufficient to 
induce the opening of the mPTP, as confirmed by the calcein-Co
2+
 assay (Fig. 21B). 
Overexpression of the c subunit induces a tendency in lower the mitochondrial Ca
2+
 uptake 
(peak amplitude: 82.34 ± 5.4 μM vs. 93.89 ± 10.6 μM [MOCK]; p > 0.05), without 
significantly affect the kinetics of Ca
2+
 influx and efflux (Fig. 21C and 21D) or cytosolic 
Ca
2+
 levels (peak amplitude: 3.03 ± 0.08 μM vs. 2.94 ± 0.07 μM [siSCR]; p > 0.05) (Fig. 
21E and 21F).  
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Figure 21. Calcium signaling during F1/FO ATP synthase c subunit overexpression in HeLa cells. The 
protein relative aboundance of HeLa cells mock transfected or transfected for 48 h with a plasmid 
encoding MYC-tagged ATP5G1 (A). Fluorescence intensity levels in the Calcein-Co2+ assay (B). HeLa 
cells were transfected as in (A) but in a combination with a plasmid encoding a mitochondrial red 
fluorescent protein (mtDsRED) (B), or in a combination with a plasmid coding for a mitochondrial (C) 
(n=16 from 4 indipendent experiments) or cytosolic (E) (n=10 from 3 indipendent experiments) 
aequorin, and then, the cells were stimulated with 100 μM histamine (Hist). Rates of mitochondrial (D) 
and cytosolic (F) Ca
2+
 accumulation and release. The data are presented as means ± SEM **p < 0.01. 
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To confirm the absence of an effect of mPTP modulation on Ca
2+
 efflux, we used a 
pharmacological approach; specifically, Cyclosporine A (CsA) and hydrogen peroxide 
(H2O2) were used as an inhibitor of the mPTP [139] and an inducer of mPTP opening, 
respectively [140].  
CsA (1 M) was added to HeLa cells 30 min before stimulation with histamine (100 M) 
and measurements of [Ca
2+
]m. As previously reported [21], CsA induced a significant 
increase in Ca
2+
 uptake (peak amplitude: 82.63 ± 2.82 μM vs. 70.2 ± 2.65 μM [VEHICLE]; 
p < 0.05) (Fig. 22A) and in the rate of Ca
2+
 accumulation in the mitochondria due to an 
increase in the mitochondrial membrane potential, which is the driving force for Ca
2+
 
accumulation. In contrast, no differences in Ca
2+ 
efflux kinetics (Fig. 22B) were observed. 
The closed state of the mPTP was confirmed using the calcein-Co
2+
 assay (Fig. 22C). 
In contrast, to pharmacologically induce mPTP opening, HeLa cells were exposed to H2O2 
(500 M) 30 min before stimulation with histamine (100 M). As expected, in the 
presence of H2O2, a significant decrease in Ca
2+
 uptake by the mitochondria was induced 
(peak amplitude: 36.52 ± 3.34 μM vs. 70.2 ± 2.65 μM [VEHICLE]; p < 0.001) (Fig. 22D). 
Regarding the Ca
2+
 influx/efflux kinetics, a significant reduction of 33% in the rate of Ca
2+
 
accumulation into the mitochondria and a significant reduction of 22% in the rate of Ca
2+
 
release from the mitochondria in the presence of H2O2 (500 M) occurred (Fig. 22E). 
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Figure 22: Modulation of the Ca
2+
 influx/efflux rates by CsA or H2O2 treatment. HeLa cells were 
transfected with a plasmid coding for a mitochondrially targeted aequorin and treated with 1 μM CsA 
for 30 min. The cells were then stimulated with 100 μM histamine (Hist) (A) (n=16 from 4 indipendent 
experiments).. Rates of mitochondrial (B) Ca
2+
 accumulation and release. Fluorescence intensity levels 
in the Calcein-Co
2+
 assay (C). HeLa cells were transfected as in (A) but in a combination with a 
plasmid encoding a mitochondrial red fluorescent protein (mtDsRED). The cells were monitored by 
fluorescence microscopy to assess the calcein signal. HeLa cells were transfected with a plasmid coding 
for a mitochondrial aequorin and treated with 500 μM H2O2 for 30 min (D and E). The cells were then 
stimulated with 100 μM histamine (Hist) (D) (n=10 from 3 indipendent experiments). Rates of 
mitochondrial (E) Ca
2+
 accumulation and release. Fluorescence intensity levels in the Calcein-Co2+ 
assay (F). HeLa cells were transfected with a plasmid encoding a mitochondrial red fluorescent protein 
(mtDsRED). The cells were monitored by fluorescence microscopy to assess the calcein signal. The 
data are presented as means ± SEM *p < 0.05, **p < 0.01, ***p < 0.001. 
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To confirm the specificity of the effect of H2O2 on mPTP opening and Ca
2+
 handling, we 
combined H2O2 (500 M) and CsA (1 M) before stimulation with histamine (100 M) 
(Fig. 23A). In such condition, histamine challenging display a partial recovering in both 
[Ca
2+
]m (peak amplitude: 32.59 ± 5.79 μM [Vehicle] vs. 51.6 ± 10.3 μM [CsA]; p < 0.05) 
and uptake rate, while no significant reduction in the Ca
2+
 efflux kinetic were observed 
(Fig. 23B). Silencing of ATP5G results in protection of mPTP opening during challenging 
with the prooxidant H2O2, in an extent comparable with treatment of CsA [21]. As 
expected HeLa cells depleted of ATP5G display a [Ca
2+
]m protected from H2O2 in both 
amplitude (peak amplitude: 32.6 ± 5.79 μM [siSCR] vs. 57.3 ± 4.96 μM [siATP5G]; p < 
0.01) and uptake speed while no significant differences were observed in the recovery 
phase of the peak (Fig. 23C and 23D). On opposite the ATP5G1 overexpression results in 
a promotion of H2O2 induced suppression of mitochondrial Ca
2+
 uptake (peak amplitude: 
47.9 ± 5.19 μM [Mock] vs. 29.2 ± 2.22 μM [ATP5G1]; p < 0.01), with a parallel inhibition 
of the uptake and release kinetics (Fig. 23E and 23F). 
Overall, the data shown that the mPTP pharmacological opening inversely correlate with 
amplitude and influx rate [Ca
2+
]m but do not affect efflux rates in living cells. 
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Figure 23: Modulation of the mPTP activity by c subunit silencing, c subunit overexpression and CsA 
treatment in combination with H2O2 treatment. HeLa cells were transfected with a plasmid coding for 
a mitochondrially targeted aequorin, treated with 1 μM CsA for 30 min and then treated with 500 μM 
H2O2 for 30 min (A and B). The cells were then stimulated with 100 μM histamine (Hist) (A) (n=10 
from 3 indipendent experiments). Rates of mitochondrial (B) Ca
2+
 accumulation and release.  
HeLa cells were transfected with a scrambled siRNA (siSCR) or a mix of siRNAs targeting ATP5G1, 
ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid coding for a mitochondrial 
aequorin for 48 h and treated with 500 μM H2O2 for 30 min (C and D). The cells were then stimulated 
with 100 μM histamine (Hist) (C). (n=10 from 3 indipendent experiments). Rates of mitochondrial (D) 
Ca
2+
 accumulation and release.  
HeLa cells were mock transfected or transfected for 48 h with a plasmid encoding MYC-tagged 
ATP5G1 in a combination with a plasmid coding for a mitochondrial aequorin and treated with 500 
μM H2O2 for 30 min (E and F). The cells were then stimulated with 100 μM histamine (Hist) (E) (n=10 
from 3 indipendent experiments). Rates of mitochondrial (F) Ca
2+
 accumulation and release.  
The data are presented as means ± SEM *p < 0.05, ***p < 0.001. 
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Multiple authors proposed that the mPTP exerts a significant effect on the mitochondrial 
Ca
2+
 efflux only during saturation of the Ca
2+
 export system [141]. To explore this, we 
monitored the effect of genetic manipulation of ATP5G by blocking the mitochondrial 
Na
+
/Ca
2+
 exchanger. 
As previously shown (Fig. 20) exposure to CGP37157 induce significant increase in 
[Ca
2+
]m during agonist stimulation with concomitant reduction of efflux rate. If mPTP 
opening extrude Ca
2+
 only during saturations of other efflux systems then c subunit 
depletion should results in a strengthened inhibition of efflux rate. In spite to this 
hypothesis, silencing of ATP5G in HeLa cells exposed to CGP37157 did not display any 
significant differences in peak amplitude when compared to siSCR-treated cells (Fig. 24A, 
peak amplitude: 86.2 ± 17.2 μM [siSCR] vs. 85.7 ± 15.93 μM [siATP5G]; p > 0.05) as also 
in uptake or release speed (Fig. 24B). 
An analogous situation was observed by ATP5G1 overexpression. As we proposed that 
ATP5G1 overexpression sensitize MPT induction, the threshold for mPTP opening should 
be reached faster by the saturation of efflux systems. Nonetheless exposure to CGP37157 
did not induce any significant variations in any of the measured indicators of mitochondrial 
Ca
2+
 homeostasis (Fig. 24C and 24D, peak amplitude: 95.23 ± 12.44 μM [Mock] vs. 81.27 
± 18.91 μM [ATP5G1]; p > 0.05). 
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Figure 24: Modulation of the mPTP activity by combined CGP37157 and c subunit silencing or c 
subunit overexpression. HeLa cells were transfected with a scrambled siRNA (siSCR) or a mix of 
siRNAs targeting ATP5G1, ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid coding 
for a mitochondrial aequorin for 48 h and treated with 10 μM CGP37157 added 2 min before 
stimulation with histamine, which was done in the continuous presence of CGP37157. (A and B). The 
cells were then stimulated with 100 μM histamine (Hist) (A) (n=10 from 3 indipendent experiments). 
Rates of mitochondrial (B) Ca
2+
 accumulation and release. HeLa cells were mock transfected or 
transfected for 48 h with a plasmid encoding MYC-tagged ATP5G1 in a combination with a plasmid 
coding for a mitochondrial aequorin and treated with 10 μM CGP37157 added 2 min before 
stimulation with histamine, which was done in the continuous presence of CGP37157. (C and D). The 
cells were then stimulated with 100 μM histamine (Hist) (C) (n=10 from 3 indipendent experiments).  
Rates of mitochondrial (D) Ca
2+
 accumulation and release. The data are presented as means ± SEM. 
 
To avoid any aspecific effect related to modulation of ATP5G expression effect of efflux 
system saturation was tested by pharmacological inhibition of mPTP by CsA. HeLa cell 
exposed to GCP37157 display peak amplitude much lower compared to the double-treated 
cells (Fig. 25A, peak amplitude: 132.2 ± 29.53 μM [CsA + CGP37157] vs. 75.84 ± 8.00 
μM [CGP37157]; p < 0.05). This also reflects in a dramatic increase in uptake rate (Fig. 
25B). In spite of the different amount of Ca
2+
 available, CsA do not induce the 
hypothesized reduction in efflux rate, but only a barely increase (Fig. 25B). 
Furthermore, as alternative route to saturation [Ca
2+
]m, we forced an increase in [Ca
2+
]m by 
overexpressing the MCU. HeLa cells overexpressing the mitochondrial Ca
2+
 uniporter 
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displayed a dramatic increase in mitochondrial Ca
2+
 uptake (peak amplitude: 62.74 ± 3.69 
μM vs. 112.14 ± 10.27 μM [MOCK]; p < 0.01), which was near 100% (Fig. 25A). As 
expected, a significant stimulation of Ca
2+
 influx was observed (approximately 97%); 
however, no significant variations in efflux were detectable (Fig. 25B). MCU 
overexpression was then combined with mPTP inhibition by CsA. Cells that were exposed 
to CsA (1 μM) and overexpressing MCU display a tendency in reduction of maximal 
[Ca
2+
]m, (peak amplitude: 112.2 ± 10.27 μM [MCU] vs. 98.9 ± 13.57 μM [MCU + CsA]; p 
> 0.05) in contrast to what was observed in mock-transfected cells (Fig. 25C and 25A). 
Nonetheless no differences were detected in the Ca
2+
 efflux rates (Fig. 25D). 
 
Figure 25: Modulation of the mPTP activity by CsA treatment in combination with CGP37157 
treatment or MCU overexpression. HeLa cells were transfected for 48 h with a plasmid coding for a 
mitochondrial aequorin and treated with 10 μM CGP37157 for 2 min, in absence or presence of 1 μM 
CsA for 30 min. (A and B). The cells were then stimulated with 100 μM histamine (Hist) (A) (n=9 from 
3 indipendent experiments). Rates of mitochondrial (B) Ca
2+
 accumulation and release. HeLa cells 
were mock transfected or transfected for 48 h with a plasmid encoding MCU-FLAG in a combination 
with a plasmid coding for a mitochondria-targeted aequorin in absence or presence of 1 μM CsA for 30 
min (C and D). The cells were then stimulated with 100 μM histamine (Hist) (C) (n=9 from 3 
indipendent experiments). Rates of mitochondrial (D) Ca
2+
 accumulation and release. The data are 
presented as means ± SEM *p < 0.05, ***p < 0.001. 
 
 65 
The efficiency of the mitochondrial Ca
2+
 efflux system has been proposed to be dependent 
upon [Ca
2+
]m. Some previously described conditions cause variations in the maximal 
[Ca
2+
]m. To avoid data misinterpretation due to this effect, we measured mitochondrial 
Ca
2+
 accumulation and release in permeabilized cells that were exposed to the same [Ca
2+
]. 
For this purpose, HeLa cells were perfused with a solution mimicking the intracellular 
milieu (IB) supplemented with 2 mM EGTA, the cells were then permeabilized with 
digitonin 30 for 1 min. The perfusion buffer was then changed to IB, which had an EGTA-
buffered [Ca
2+
] of 1 M. The cells were finally perfused with IB that was supplemented 
with Ruthenium Red (RuR), which is an inhibitor of the mitochondrial Ca
2+
 uniporter, and 
deprived of free Ca
2+
 to induce a maximal rate of Ca
2+
 release from the mitochondria. The 
same experiment was performed during modulation of c subunit expression or in the 
presence of CsA (1 M), which was added 30 min before the beginning of the 
measurement. Exposure of permeabilized cells transfected with scrambled siRNA to 
external [Ca
2+] (1 μM) induced a rapid increase in [Ca2+]m that was stabilized at a value of 
3.09 ± 0.24, analogous to the [Ca
2+
]m that was reached in cells transfected with siATP5G 
(Fig. 26A, plateau 2.89 ± 0.22 μM). The switch to a Ca2+-free condition in the presence of 
RuR induced a dramatic decrease in the [Ca
2+
]m, and the rate at which this occurred 
appeared to be identical between cells transfected with scrambled siRNA or depleted in 
ATP5G (Fig. 26B). Negligible variations in both plateau levels or Ca
2+
 efflux rates were 
detected also when overexpressing ATP5G1 (Fig. 26C and 26D, plateau level: 2.03 ± 0.26 
μM [Mock] vs. 2.34 ± 0.43 μM [ATP5G1]; p > 0.05) or during exposure to CsA (Fig. 24E 
and 24F, plateau level: 1.72 ± 0.28 μM [Vehicle] vs. 1.65 ± 0.74 μM [CsA]; p > 0.05). 
This confirmed that mPTP does not affect maximal mitochondrial Ca
2+
 efflux rate in 
standardized [Ca
2+
]m. 
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Figure 26: Modulation of the mPTP activity by c subunit silencing, c subunit overexpression and CsA 
treatment in permeabilized cells. HeLa cells were transfected with a scrambled siRNA (siSCR) or a 
mix of siRNAs targeting ATP5G1, ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid 
coding for a mitochondrial aequorin for 48 h (A and B) (n=9 from 3 indipendent experiments); HeLa 
cells were mock transfected or transfected for 48 h with a plasmid encoding MYC-tagged ATP5G1 in a 
combination with a plasmid coding for a mitochondrial aequorin (C and D) (n=10 from 3 indipendent 
experiments); HeLa cells were transfected with a plasmid coding for a mitochondria-targeted aequorin 
and treated with 1 μM CsA for 30 min or Vehicle (E and F) (n=10 from 3 indipendent experiments). 
The cells were then digitonin-permeabilized and stimulated with 1 μM [Ca2+] in EGTA-buffered 
buffer. Calcium efflux was stimulated by a calcium-free buffer supplemented with Ruthenium Red 
(RuR). Rate of mitochondrial Ca
2+
 release after Ca
2+
 deprivation and RuR perfusion (B, D and F)). The 
data are presented as means ± SEM. 
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Nonetheless in such experimental conditions a possible effect of mPTP in efflux kinetic 
could be overcome by the activity of mNCX and the Ca
2+
/H+ antiporter. Ca
2+
 efflux rates 
where monitored in presence of the mitochondrial Na
+
/Ca
2+
 exchanger CGP37157 elicited 
by 2 μM RuR and in presence of external Ca2+. The presence of CGP37157 dramatically 
increase mitochondrial Ca
2+
 uptake causing fast aequorin consumption when external Ca
2+
 
1 μM was added ([Ca2+]m > 14 μM data not show). In this second group of permeabilized 
cells Ca
2+
 uptake was then elicited by external Ca
2+
 0.5 μM. Administration of RuR induce 
slow (but not absent) Ca
2+
 release from mitochondrial matrix in scrambled, siRNA-
trasfected HeLa cells. Interestingly cells transfected with siRNA for ATP5G1 display the 
same [Ca
2+
]m at the plateau while the efflux speed, in presence of RuR was consistently 
(but not significantly) reduced suggesting a possible role for mPTP in Ca
2+
 efflux in this 
condition (data not shown). According to this hypotesys the efflux rate in HeLa 
overexpressing ATP5G1 display a strong (but not significant) increase (Fig. 27A and 
27B). Finally when cells were pretreated with CsA (Fig. 27C and 27D) the extrusion rate 
appear completely identical to the once measured in untreated cells, indicating that mPTP 
was not responsible for remaining Ca
2+
 leak from mitochondrial matrix. 
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Figure 27: Modulation of the mPTP activity by combined CGP37157 and c subunit overexpression or 
CsA treatment in permeabilized cells. HeLa cells were mock transfected or transfected for 48 h with a 
plasmid encoding MYC-tagged ATP5G1 in a combination with a plasmid coding for a mitochondrial 
aequorin (A and B) (n=9 from 3 indipendent experiments); HeLa cells were transfected with a plasmid 
coding for a mitochondria-targeted aequorin and treated with 1 μM CsA for 30 min or Vehicle (C and 
D) (n=9 from 3 indipendent experiments). The cells were then digitonin-permeabilized and stimulated 
with 0.5 μM [Ca2+] in EGTA-buffered buffer and in presence of CGP37157 10 μM. Calcium efflux was 
stimulated by 2 μM Ruthenium Red (RuR). 
Rate of mitochondrial Ca
2+
 release after Ca
2+
 deprivation and RuR perfusion (B and D). The data are 
presented as means ± SEM. 
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Discussion 
 
Correct Ca
2+
 uptake into the mitochondria is essential for mitochondrial oxidative 
phosphorylation, but excessive Ca
2+
 uptake leads to cell death [142]. Therefore, the 
balance between Ca
2+
 influx and efflux is fundamental for correct intracellular homeostasis 
and is extensively regulated by influx (through the mitochondrial Ca
2+
 uniporter) and 
efflux (through the Na
+
/Ca
2+
 or H
+
/Ca
2+
 exchanger) systems [82]. 
Some authors have proposed that the mPTP is a component of the Ca
2+
 efflux system due 
to the non-specific channel properties that were observed during its opening [45, 81]. 
These reports are based mainly on pharmacological inhibition of the mPTP by 
cyclosporine A (CsA, which targets PPIF) or by knocking down PPIF, which causes 
typical alterations in mitochondrial Ca
2+
 homeostasis that could be associated with 
alterations in the mitochondrial Ca
2+
 efflux (especially alterations in the maximal [Ca
2+
]m 
and Ca
2+ 
extrusion rates). On the other hand, several other reports have indicated the 
opposite [82, 83], which suggests a different function for CsA in affecting Ca
2+ 
homeostasis. 
Driven by our recent work suggesting that the c subunit of the F1/FO ATP synthase is a 
component of the mPTP, we have focused our attention on the involvement of the mPTP in 
mitochondrial Ca
2+ 
homeostasis under non-pathological conditions. The novelty of our 
study lies in the regulation of mPTP activity by manipulating the c subunit of the F1/FO 
ATP synthase and measuring the [Ca
2+
]m and [Ca
2+
]c using the pH-independent, 
luminescent, Ca
2+
-sensitive probe, aequorin [91]. 
Measurements of [Ca
2+
]m revealed a minimum reduction in mitochondrial Ca
2+
 loading 
after c subunit silencing but no variations in the rate of Ca
2+
 release from the mitochondria 
were observed. Furthermore, no changes in the cytosolic Ca
2+
 levels were observed. As 
previously shown in this condition, we forced the closing of the mPTP, and the cells were 
protected from damage.  
An analogous situation occurs when the c subunit is overexpressed, which forces the 
opening of the mPTP. In this case, mitochondrial Ca
2+
 accumulation is reduced, but no 
changes in the rate of Ca
2+
 influx and efflux occur.  
In both cases the observed variations in peak amplitude correlates with the decrease in the 
mitochondrial membrane potential that is induced by c subunit silencing or overexpression, 
which we recently reported [91]. The overall modulation of c subunit expression suggested 
that, under physiological conditions in HeLa cells, mPTP is not directly involved in the 
Ca
2+
 efflux mechanism, and an indirect effect could be hypothesized instead. 
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We previously reported that, in this cell line, c subunit silencing generates a moderate 
reduction of the MMP, which is the opposite of the significant depolarization that occurs 
upon c subunit overexpression. Variations in m, which is the driving force for Ca
2+
 
accumulation in the mitochondrial matrix, could produce the exact effects on [Ca
2+
]m and 
uptake rate that were observed in this model. To validate these results, we took advantage 
of the well-known PPIF inhibitor CsA that was reported to be capable of increasing the m 
and [Ca
2+
]m [143, 144]. After CsA treatment, a significant increase in mitochondrial Ca
2+
 
uptake and the peak amplitude occurred, but, again, no differences in the rate of 
mitochondrial Ca
2+
 efflux were observed (which was in accordance with the observation of 
c subunit silencing).  
However, we cannot completely ignore the several respectable reports proposing that there 
is an effect of the mPTP on mitochondrial Ca
2+
 efflux. Most of these reports were based on 
PPIF inhibition or knock out. It could then be speculated that PPIF could somehow affect 
other participants of the Ca
2+
 efflux system, as proposed by Wei and co-workers [82], and 
possibly generate a conformational rearrangement upon interaction with other proteins due 
to its peptidyl-prolyl isomerase activity. 
It could be argued that c subunit overexpression did not lead to an mPTP opening event 
sufficient to generate a detectable Ca
2+
 efflux. To test this hypothesis, we induced mPTP 
opening through the use of the prototypic, pro-oxidant H2O2. Exposure to this stress agent 
results in mPTP opening with consequent reduction in the maximal [Ca
2+
]m after agonist 
exposure, and an increase in Calcein quenching by cobalt. In this condition a decrease in 
the mitochondrial Ca
2+
 influx and efflux were observed, in agreement with the reduced 
driving force, while the model of an opened aspecific Ca
2+
 channel (as the mPTP would 
be) should produced a significant increase in Ca
2+
 efflux rate. 
Nonetheless, although the [Ca
2+
]m is partially recovered, in cells silenced for ATP5G or 
pretreated with CsA, protection from mPTP does not modify the Ca
2+
 efflux kinetics. As 
opposite the ATP5G1 overexpression promotes the H2O2 induced mPTP opening causing a 
further reduction in maximal [Ca
2+
]m under agonist stimulation. In spite of this, the efflux 
rate do not display a significant stimulation, but rather a bare inhibition. These 
observations provide strong confirmation that, even following a potent induction of its 
opening, the mPTP does not participate in Ca
2+
 efflux. We previously confirmed that, 
induction of mPTP by H2O2 cause a slow m dissipation (probably due to the induction of 
the low conductance mode of mPTP) [21, 145]. During protection or induction of mPTP 
opening, [Ca
2+
]m recovering phase seem to correlate with the levels of m previously 
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observed in such conditions [21], strengthening the hypothesis that a possible modulation 
of [Ca
2+
]m by mPTP should indirectly occurs, due to regulation of m. 
It was proposed that the effects of the mPTP on Ca
2+
 efflux kinetics could be relevant as a 
“safe valve” only in mitochondria with a saturated Ca2+ efflux system [141], which is 
analogous to what was observed in Ca
2+
 retention capacity experiments that largely used 
isolated mitochondria to determine the threshold for mPTP opening. To challenge this 
hypothesis in living cells, we combined the c subunit expression with the blockade of 
mitochondrial Na
+
/ Ca
2+
 antiporter through the use of CGP37157. Interestingly all the 
tendencies previously observed while silencing or overexpressing c subunit were 
completely masked by the use of CGP37157, suggesting that sustained [Ca
2+
]m levels are 
not sufficient to induce a calcium efflux through mPTP. Further an effect of on [Ca
2+
]m 
was still observable, while blocking mNCX, as an increase in [Ca
2+
]m and in influx rate 
(characters dependent on m), nonetheless efflux rate was, still, not affected.  
An alternative Ca
2+
 overload approach was proposed. Recently several components of the 
mitochondrial calcium uptake machinery has been revealed [64]. Core element of the 
MCU system is the proteic channel product of the CCDC109a gene (MCUa [40, 41]. 
Overexpressing the MCU, as expected, resulted in an extraordinary increase in the Ca
2+
 
influx rate and [Ca
2+
]m. Such an increase was not further stimulated by the mPTP opening 
inhibition through treatment with CsA, which suggested that the mitochondrial network 
was near its maximal uptake capacity. Interestingly MCUa overexpression also resulted in 
a reproducible tendency in increase also the Ca
2+
 efflux rate. Treatment with CsA did not 
generate any significant effects on calcium efflux rates of MCUa-overexpressing cells. 
Overall these results clearly indicates that overload of [Ca
2+
]m, in our cell model, is not 
sufficient to induce a mPTP dependent Ca
2+
 efflux. 
The Ca
2+
 efflux system is dependent upon [Ca
2+
]m, which is exposed; and modulation of 
the expression of the c subunit as well as exposure to CsA results in alterations of the 
[Ca
2+
]m. 
To avoid misinterpretation of the data due to different values of [Ca
2+
]m, Ca
2+
 efflux 
measurements were performed in permeabilized cells that had been stimulated with 
external Ca
2+
 (1 μM) to obtain a stable level of [Ca2+]m in the control mitochondria 
compared. After that plateau was reached, the external Ca
2+
 was removed, and the MCU 
inhibitor Ruthenium Red was added to avoid Ca
2+
 reuptake. The rate of Ca
2+
 release from 
the mitochondria under these conditions has to be considered as the maximum efflux speed 
that could be reach and revealed no significant differences after mPTP inhibition with CsA 
as also during ATP5G silencing or its overexpression. It is reasonable to assume that, being 
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mitochondria in permeabilized cells energized by addition of ADP, pyruvate and succinate, 
the efflux rate is driven mostly by the mNCX and to the H
+
/Ca
2+
 exchangers. 
Nonetheless a further induction of efflux system saturation by inhibition of mitochondrial 
Na
+
/ Ca
2+
 antiporter (in the presence of external Ca
2+
) and MCU inhibition (by RuR) 
generate a Ca
2+
 leak from mitochondrial matrix independent on mPTP inhibition (by 
ATP5G silencing or CsA administration) as also to its stimulation (by ATP5G1 
overexpression) thus ascribable only to the H
+
/Ca
2+
 exchanger excluding the possible 
involvement of the mPTP as a component of the Ca
2+
 efflux system even when 
standardized Ca
2+
 concentrations where achieved.  
The presented results suggest that, in spite of what can be observed in isolated 
mitochondria, the mPTP has a Ca
2+
-induction threshold that is too high to be reached in 
living cells, and this is most likely due to the high efficiency of the Na
+
/ Ca
2+
 and H
+
/Ca
2+
 
exchangers, which can could compete with and overcome the mPTP. It should also be 
considered that the Ca
2+
 efflux from mitochondria is an energetically unfavorable process 
due to the strong electrochemical gradient, which is negative in the matrix. This allows for 
passive import into the matrix, as occurs during MCU. If the current model for the mPTP, 
which states that it forms a nonspecific channel, is correct, then its partial opening even in 
the presence of a reduced m (as it apparently occurs in its low conductance mode) should 
favor import instead of efflux. In contrast, efflux through a channel would be expected on 
de-energized mitochondria, as was reported for the MCU [146]. Still has to be considered 
that inhibition of mPTP induce increase in Ca
2+
 loading capacity that can lead to 
generation of toxic Ca
2+
 phosphorous rich precipitates [147]. Present results do not exclude 
mPTP participation in this phenomenon, but it would suggest that it could be indirectly 
involved. Opening of mPTP do not directly allow Ca
2+
 transport, but rather would 
dissipated mitochondrial membrane potential facilitating Ca
2+
 efflux from conventional 
Ca
2+
 efflux system or by inverse transportation through MCU. 
Altogether, these data demonstrate that, under physiological conditions, the mPTP is a 
dispensable element for mitochondrial Ca
2+
 homeostasis and, especially, for mitochondrial 
Ca
2+
 release at least in our cell model. 
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Materials and methods 
 
Cell culture and transfection.  
Mouse embryonic fibroblast (MEFs) were maintained in a humidified 5% CO2, 37°C 
incubator in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS; Life technologies, 10270) 100 U/ml penicillin (EuroClone, 3001D), 
100 mg/ml streptomycin (EuroClone, 3000D) were infected by recombinant adenovirus 
expressing mitochondrially or cytosolic aequorin, mtGFP and MCU-GFP. For aequorin 
measurements, the cells were seeded before transfection onto 13mm glass coverslips and 
allowed to grow to 50% confluence. For mitochondrial membrane potential analysis by 
fluorescence microscopy cells were seeded on 24mm glass coverslip. For immunoblotting 
analysis, cells were seeded on 6 well plates in the same conditions of growth. 
HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) (Euroclone), 
supplemented with 10% fetal bovine serum (FBS, Gibco) and penicillin/streptomycin 
(Gibco), in atmosphere of 5% (v/v) carbon dioxide in air at 37 °C. Cells were seeded 24 h 
before transfection onto glass coverslips (13mm in diameter for aequorin experiments or 
24mm for microscopy experiments), or on 10cm Petri dishes for immunoblotting and cell 
death experiments.  
Cortical/hippocampal neurons were prepared from 1- to 3-day-old newborn rats, [148], and 
neurons were resuspended in Neurobasal A Medium (Gibco) with supplement B-27 
(Gibco), GlutaMax (Gibco) and penicillin/streptomycin (Gibco) rigorously at 37°C and 
plated onto glass coverslips, coated with poly-D-lysine (Sigma). 
HeLa were allowed reach 50% confluence before transfection. Cultured neurons were 
transfected at 3 days in vitro (DIV 3). RNA interference experiments were performed by 
transfecting cells with a commercial control siRNA (AllStars RNAi Controls, herein 
referred to as siSCR), with a validated siRNA specific for ATP5A1 (siATP5A1, sense 5'-
GGC UGG AUU UGA AGC UUA AdTdT-3') or with a mix of siRNAs targeting ATP5G1 
(5'-GCU CUG AUC CGC UGU UGU AdTdT-3'), ATP5G1 (5'-CGG AGA UAC UGA 
CAG AUG AdTdT-3') and ATP5G3 (5'-AGG GCU CUA CGG UAU UUA AdTdT-3'), all 
purchased from Qiagen. siRNAs were transfected by means of the HiPerfect® transfection 
reagent, as per manufacturer’s instructions [149]. For transient overexpression 
experiments, a pCMV6 entry- based plasmid coding for a MYC-tagged variant of ATP5G1 
under the control of the CMV immediate early promoter (RC200292) was obtained from 
OriGene. A pcDNA3 based plasmid coding for MCU-flag tagged was gift from prof. 
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Rosario Rizzuto from University of Padua, pcDNA3 empty vector was used as Mock. For 
the quantification of mitochondrial ATP levels, a VR1012-based construct encoding a 
mitochondrially targeted variant of the Photinus pyralis luciferase under the control of the 
CMV immediate early promoter was employed [120]. For the study of mitochondrial 
morphology, a pcDNA3-based plasmid coding for a mitochondrially targeted variant of 
GFP (mtGFP) under the control of the CMV immediate early promoter was used [150]. 
For the quantification of cell death in neurons, a pcDNA3-based construct coding for GFP 
under the control of the CMV immediate early promoter was used [151]. Plasmid 
transfections were performed via the standard Ca
2+
 phosphate procedure [152].  
 
MEFs cells synchronization protocol. MEFs cells were subjected to a synchronization 
protocol by the use of Serum Starvation (SS). Cells are seeded in the wells and then 
subjected to SS, in particular with DMEM high glucose supplemented with only 0.1% FBS 
(the total absence of serum leads cells to autophagy) for 48-72 h. After this time cells are in 
G0 phase. Cells are then washed with PBS and subsequently additioned with complete 
medium (Serum Readdition (SR)). After 8 h of SR cells are in G1 phase, after 24 h in G1/S 
phase, after 28 h in S phase. For the remaining phases, the addition of Nocodazole 100 
ng/ml induces cell cycle progression, by microtubules depolymerization. After 24 h of SR 
plus 4 or 8 h of Nocodazole treatment (in SR medium) cells are in G2 and M phase 
respectively.  
 
RNA extraction and gene expression analyses. For the expression analysis of ATP5G1, 
ATP5G2, and ATP5G3 silencing, total RNA was purified from HeLa cells transfected with 
scrambled or ATP5G1 siRNAs (siATP5G1, 2 and 3), for 48 h following the standard 
TRIzol protocol. To analyze mRNA expression, qRT-PCR was performed on 500 ng of 
total RNA using oligo dT (Fermentas) and random primers (Gibco). Quantitative PCR 
reaction was performed using Qiagen Taq DNA Polymerase and EvaGreen (Biotium Inc). 
The following oligonucleotides were used as primers for the qPCR reaction:  
ATP5G1-fw, 5’-GCTGAGACCAAGGGCTAAAG-3’;  
ATP5G1-rv, 5’-CGGATCAGAGCTGGAGAAATG-3’;  
ATP5G2-fw, 5’-TGGAACTGTGTTTGGGAGC-3’;  
ATP5G2-rv, 5’-TGGCAAAGAGGATGAGAAAGG-3’;  
ATP5G3-fw, 5’-TGGTTCTGGTGCTGGTATTG-3’;  
ATP5G3-rv, 5’-GAGACCCATAGCTTCAGACAAG-3’.  
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Reactions were incubated in a 96-well PCR plate at 95°C for 15 min, followed by 40 
cycles of 95° C for 30 sec and 58°C for 1 min, on Bio-Rad-Chromo4 Real Time thermal 
Cycler.  
(available at http://fiji.sc/) and the parallel iterative deconvolution plugin.  
 
Aequorin measurements. Probes used are chimeric aequorins targeted to the cytosol 
(cytAEQ) and mitochondria (mtAEQmut). “AEQ” refers to wild-type aequorin, and 
“AEQmut” refers to a low affinity D119A mutant of aequorin. For the experiments with 
cytAEQ and mtAEQmut, MEFs cells were incubated with 50 mM coelenterazine (Fluka, 
7372) for 1–2 h in complete DMEM high glucose. HeLa cells were incubated with 5 mM 
coelenterazine (Fluka, 7372) for 1–2 h in Krebs-Ringer buffer (KRB). A coverslip with 
transfected cells was placed in a perfused thermostated chamber located in close proximity 
to a low-noise photomultiplier with a built-in amplifier/discriminator. All aequorin 
measurements were performed in KRB supplemented with 1 mM CaCl2. Agonist was 
added to the same medium as specified in figure legends. All experiments were terminated 
by lysing cells with 100 μM Triton in a hypotonic Ca2+-containing solution (10 mM CaCl2 
in H2O) thus discharging the remaining aequorin pool. The output of the discriminator was 
captured by a Thorn EMI photon-counting board and stored in an IBM-compatible 
computer for further analyses. The aequorin luminescence data were calibrated offline into 
[Ca
2+
] values using a computer algorithm based on the Ca
2+
 response curve of wild-type 
and mutant aequorins. In the experiments with permeabilized cells, a buffer mimicking the 
cytosolic ionic composition, (intracellular buffer) was used: 130 mM KCl, 10 mM NaCl, 2 
mM K2HPO4, 5 mM succinic acid, 5 mM malic acid, 1 mM MgCl2, 20 mM HEPES, 1 mM 
pyruvate, 0.5 mM ATP (pH 7 at 37 °C). Intracellular buffer was supplemented with 2 mM 
EGTA and 2 mM HEDTA-buffered [Ca
2+] 1 μM or 0.5 μM (intracellular buffer/Ca2+), 
calculated with the Chelator software [153]. HeLa cells were permeabilized by a 1-min 
perfusion with 50 μM digitonin (added to intracellular buffer/EGTA) during luminescence 
measurements. Mitochondrial Ca
2+
 uptake rate was calculated as the first derivative by 
using Microsoft Excel (Microsoft Co.); all the slopes were calculated at the same [Ca
2+
]m 
to ensure comparable activity of efflux system. 
 
Quantification of cell death. Dead cells were quantified by virtue of their ability to take 
up propidium iodide (PI), reflecting the breakdown of the plasma membrane [154, 155]. To 
this aim, HeLa cells were processed as indicated in the Tali® Apoptosis Kit (Molecular 
Probes-Life Technologies) and analyzed on a Tali® Image-Based cytometer (Invitrogen-
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Life Technologies). Conversely, rat neurons were stained with 1 μM PI (Molecular Probes-
Life Technologies) for 5 min at room temperature (RT), then fixed with 4% 
paraformaldehyde (PFA) and stained with 1 μM Hoechst 33342 (Molecular Probes-Life 
Technologies) for 20 min at RT. Coverslips were then mounted on slides and analyzed on 
an Axiovert 200M microscope (Carl Zeiss) equipped with a 40× water immersion objective 
(N.A. 1.2, from Carl Zeiss) and a CoolSnap HQ CCD camera (Photometrics). Fifty random 
fields per condition were acquired in MetaMorph® (Molecular Devices) and images were 
analyzed with CellProfiler (Broad Institute) using a customized pipeline for the 
quantification of PI
+
 GFP
+
 cells. 
 
Calcein-Co
2+
 assays. HeLa Cells were loaded with 1 mM calcein acetoxymethyl ester and 
Co2+ as instructed by the Image-IT® LIVE Mitochondrial Transition Pore Assay Kit 
(Molecular Probes-Life Technologies). Cells were then imaged by means of 490 ± 20 nm 
excitation and 525 nm longpass emission filters on a Axiovert 200M fluorescence 
microscope equipped with a 40× water immersion objective (N.A. 1.2, from Carl Zeiss). 
Finally, images were analyzed with MetaMorph® and quenching rates were determined as 
the slopes of the fluorescence trace over a period of 60 sec post-stimulation. 
 
Quantification of Δψ. Cells were loaded with 1 nM tetramethylrhodamine methyl ester 
(TMRM, from Molecular Probes-Life Technologies) in complete DMEM high glucose for 
MEFs cells and in Krebs-Ringer buffer supplemented with 250 μM sulfinpyrazone for 
HeLa cells, then placed in a humidified chamber at 37°C and imaged with a LiveScan 
Swept Field Confocal Microscope (Nikon Instruments Inc.) equipped with a 60× oil 
immersion (N.A. 1.4, from Nikon Instruments Inc.) every 30 sec for 30 min. TMRM 
fluorescence was analyzed by means of the NIS Elements software package (Nikon 
Instruments Inc.), and depolarization rates were defined as the slopes of the fluorescence 
trace over a period of 10 min post-stimulation. 
 
Quantification of mitochondrial ATP. HeLa cells expressing a mitochondrially targeted 
variant of the Photinus pyralis lucifer- ase were perfused with a modified Krebs-Ringer 
buffer containing 125 mM NaCl, 5 mM KCl, 1 mM Na3PO4, 1 mM MgSO4, 1 mM CaCl2, 
20 μM luciferin and 20 mM HEPES buffer (pH 7.4 at 37°C), and luciferin-dependent 
luminescence was moni- tored with a customized luminometer (Elettrofor), as previously 
described [120]. 
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Analysis of mitochondrial morphology. HeLa cells expressing a mitochondrially targeted 
variant of GFP [151] were imaged with an IX-81 automated epifluorescence microscope 
(Olympus) equipped with a 60× oil immersion objective (N.A. 1.35, from Olympus) and 
an ORCA-R CCD camera (Hamamatsu Photonics K.K.). Selected cells were followed over 
time, and z-stacks were subjected to digital deconvolution by means of a Wiener 
deconvolution filter and a theoretical point-spread function provided by the Xcellence 
software (Olympus). GFP+ objects were quantified with the “3D object counter” plug-in of 
the open-source Fiji software (freely available at http://fiji.sc/), whereas 3D representations 
were obtained with the “3D Viewer” plug-in. 
 
Immunofluorescence microscopy. Immunofluorescence microscopy was performed 
according to standard procedures [156]. Briefly, cells were fixed in 4% PFA for 20 min at 
RT, washed three times in PBS and permeabilized with 0.1% Triton X-100 (v:v in PBS) 
for 5 min at RT. Thereafter, unspecific binding sites were blocked by incubating cells in 
2% powdered milk (w:v in PBS) for 1 h at RT. Cells were then incubated overnight at 4°C 
with primary antibodies specific for HSPD1 (1:100 in blocking buffer) or MYC (1:25 in 
blocking buffer) (both from Abcam). Finally, primary antibodies were revealed by means 
of appropri- ate AlexaFluor 488® and AlexaFluor 594® conjugates (Molecular Probes-
Life Technologies). Images were acquired on an Axiovert 220 M microscope equipped 
with a 100× oil immersion Plan Neofluar® objective (N.A. 1.3, from Carl Zeiss) and a 
CoolSnap HQ CCD camera. Each field was acquired over 21 z-planes spaced by 0.5 μm, 
and z-stacks were deconvoluted with the “Parallel Iterative Deconvolution” plug-in of Fiji. 
 
Immunoblotting. To obtain whole-cell extracts, cells were washed, harvested and lysed in 
RIPA buffer (50 mM TRIS-HCl pH 7.8, 150 mM NaCl, 1% IGEPAL CA-630, 0.5% 
sodium deoxycholate, 0.1% SDS, 1 mM dithiothreitol) supplemented with 2 mM Na3VO4, 
2 mM NaF, 1 mM phenylmethylsulfonyl fluoride and Complete Protease Inhibitor 
Cocktail® (Roche Diagnostics Corp.). Alternatively, cytosolic extracts were obtained by 
digitonin permeabilization, as previously described.74 Thereafter, protein extracts (30 
μg/lane) were separated on precast 4–12% SDS-PAGE gels (Life Sciences), 
electrotransfered onto PVDF membranes (Bio-Rad) and probed with antibodies specific for 
Cyclin A (non-commercial), pHH3 (Millipore), MCU (Sigma), p27 (BD Biosciences), the 
FO a subunit (Abcam), the FO c subunit (Abcam), the F1 α subunit (Abcam), cytochrome c 
(BD Biosciences) and VDAC1 (Abcam). An antibody specific for β actin (Sigma-Aldrich) 
and for Skp1 (Santa Cruz) were used to monitor equal lane loading. Finally, membranes 
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were incubated with appropriate horseradish peroxidase-conjugated secondary antibodies 
(Southern Biotech), followed by chemiluminescence detection with the SuperSignal West 
Pico® reagent and CL-XPosure® X-ray films (both from Thermo Scientific-Pierce). 
 
Cell cycle analysis by Tali® Image-Based Cytometer. It is a 3-channel (bright field, 
green fluorescence, red fluorescence) benchtop assay platform that uses state-of-the-art 
optics and image analysis to perform assays for cells in suspension, including GFP and 
RFP expression, apoptosis, cell viability (live, dead, and total cells), cell counting and cell 
cycle assays.  
Cells previously infected with an adenovirus expressing mtGFP or MCU-GFP and cells not 
infected were collected in a tube and centrifuged 250 x g for 5 min at 4 ° C, resuspended in 
an appropriate volume of medium and counted. At this point, it is taken a number of cells 
in a range between 1 x 10
5
 and 5 x 10
6
. Cells are centrifuged 500 x g for 5 min at 4 °C, the 
pellet is resuspended in PBS and centrifuged again. PBS is removed and cells are 
resuspended in 70% of cold ethanol and are stored at -20 °C at least for 24 h. Cells are then 
centrifuged 500 x g for 5 min at 4 °C and the pellet resuspended in 1 ml of PBS. After 
another centrifugation 500 x g for 10 min at 4 °C pellet is resuspended in 200 μl of Tali® 
Cell Cycle Solution (containing Propidium Iodide (PI) and RNAse) and in 30 min at RT 
cells are ready to be analyzed. 
 
Cell cycle analysis by FACS (Fluorescence-Activated Cell Sorting). Samples were 
prepared as previously described for cell cycle analysis by Tali® Image-Based Cytometer, 
but at the end cells were resuspended in a solution home made containing PI and RNAse. 
 
Statistical procedures. Unless otherwise indicated, assays were performed in triplicate 
independent instances, yielding comparable results. Data, which are presented as means ± 
SEM, were analyzed with Microsoft Excel (Microsoft Co.). Statistical significance was 
determined by means of ANOVA followed by two-tailed unpaired Student’s t-tests. p 
values < 0.05 were considered statistically significant. 
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